# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY AND INSTRUMENT COMBINATION TEMPLATE

A. 510(k) Number:

K161816

# B. Purpose for Submission:

To obtain a substantially equivalent determination for a premarket notification for the BacT/ALERT VIRTUO Microbial Detection System (VIRTUO) for use with BacT/ALERT SA, SN, and PF Plus blood culture bottles inoculated with human blood specimens and for FA Plus and FN Plus blood culture bottles inoculated with human blood or sterile body fluid (SBF) cultures.

# C. Measurand:

Growth of aerobic, anaerobic and facultative microorganisms in BacT/ALERT FA Plus, FN Plus, PF Plus, SA, SN bottles from blood and/or sterile body fluid cultures.

# D. Type of Test:

BacT/ALERT VIRTUO is a continuous monitoring blood culture system to be used in conjunction with BacT/ALERT SA, SN, FA Plus, FN Plus and PF Plus blood culture bottles. These blood culture bottles contain liquid culture media for recovery of microorganisms from blood and/or sterile body fluids. Colorimetric sensors are embedded in each bottle and reflected light is used to monitor the presence and production of carbon dioxide generated by the growing organism.

# E. Applicant:

bioMérieux, Inc.

# F. Proprietary and Established Names:

BacT/ALERT® VIRTUOTM Microbial Detection System (VIRTUO)   
BacT/ALERT® FA Plus Culture Bottle (FA Plus)   
BacT/ALERT® FN Plus Culture Bottle (FN Plus)   
BacT/ALERT® PF Plus Culture Bottle (PF Plus)   
BacT/ALERT® SA Culture Bottle (SA)   
BacT/ALERT® SN Culture Bottle (SN)

# G. Regulatory Information:

1. Regulation section: 21 CFR 866.2560, Microbial Growth Monitor

2. Classification: Class I

3. Product code: MDB

4. Panel: 83, Microbiology

# H. Intended Use:

1. Intended use(s):

BacT/ALERT® VIRTUOTM Microbial Detection System is an automated microbial test system capable of incubating, agitating, and continuously monitoring for the detection of aerobic, facultative, and anaerobic microorganism growth from blood and other normally sterile body fluids.

2. Indication(s) for use: Same as the intended use

3. Special conditions for use statement(s): Prescription Use Only

4. Special instrument requirements: BacT/ALERT VIRTUO Microbial Detection System is indicated for use only with BacT/ALERT FA Plus, FN Plus, PF Plus, SA, and SN bottles.

# I. Device Description:

The VIRTUO system is the next generation of the bioMérieux BacT/ALERT Microbial Detection System. This blood culture instrument consists of an incubator, agitation

mechanism, robotic apparatus for automated loading and unloading of bottles and a tactile graphical interface. VIRTUO is used in conjunction with existing, commercialized BacT/ALERT reagent bottles for clinical use (BacT/ALERT SA, SN, FA Plus, FN Plus and PF Plus culture bottles). The VIRTUO system utilizes a colorimetric sensor and reflected light to monitor the presence and production of carbon dioxide $\left( \mathrm { C O } _ { 2 } \right)$ dissolved in the culture medium. If microorganisms are present in the inoculated sample, carbon dioxide is produced as the organisms metabolize the substrates in the culture medium. When growth of the microorganisms produces $\mathrm { C O } _ { 2 }$ , the color of the gas-permeable sensor installed in the bottom of each culture bottle changes from blue-green to yellow. The color change results in an increase of reflectance units monitored by the system. The VIRTUO optically monitors the reflectance of each bottle over time and will store and interpret readings against algorithms, which are embedded in the firmware and/or software.

The VIRTUO system is modular with an A Unit, which is the main unit of the instrument and B Units, which are adjacent to the A Unit and are identical except for the following features:

A Units can be used alone and have large and small LCD/Touchscreens mounted on the front chassis. A Units can also support an external PC.   
B Units can only be used in conjunction with an A unit and have only a small touchscreen display. The bottle loading area of the B Unit includes a removable plastic housing.

In the Standalone Configuration a customer can have a single (A Unit) instrument or can have a bank of instruments (A Unit $^ +$ up to three B Units) that can stand alone or be connected to a customer network. Each instrument cabinet contains 16 racks with space for 27 bottles per rack for bottle monitoring. Four cells are dedicated for calibration standards. An instrument (either an A Unit or B Unit) has a total capacity of 432 cells.

# J. Substantial Equivalence Information:

1. Predicate device name(s): BacT/ALERT 3D Microbial Detection System

2. Predicate 510(k) number(s): K903505

3. Comparison with predicate:

<table><tr><td colspan="3" rowspan="1">Similarities</td></tr><tr><td colspan="1" rowspan="1">Item</td><td colspan="1" rowspan="1">DeviceK161816</td><td colspan="1" rowspan="1">PredicateK903505</td></tr><tr><td colspan="1" rowspan="1">Intended Use</td><td colspan="1" rowspan="1">BacT/ALERT VIRTUOMicrobial Detection System isan automated microbial testsystem capable of incubating,agitating, and continuouslymonitoring for the detection ofaerobic, facultative, andanaerobic microorganismgrowth from blood and othernormally sterile body fluids</td><td colspan="1" rowspan="1">The BacT/ALERT 3DMicrobial Detection System isa totally automated testsystem capable of incubating,agitating, and continuouslymonitoring aerobic andanaerobic media inoculatedwith patient specimenssuspected of havingbacteremia, fungemia, and/ormycobacteremia</td></tr><tr><td colspan="1" rowspan="1">Specimen types</td><td colspan="1" rowspan="1">Human blood andnormally sterile body fluids</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Bottle Types</td><td colspan="1" rowspan="1">For use with FA Plus, FN Plus,PF Plus, SA, and SN culturebottles</td><td colspan="1" rowspan="1">For use with FA Plus, FNPlus, PF Plus, SA, SN, MP,FA, and FN culture bottles</td></tr><tr><td colspan="1" rowspan="1">Detection Technology</td><td colspan="1" rowspan="1">Reflection change ofcolorimetric sensor over timeto measure metabolic reactantsproduced from organismgrowth</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Data Analysis</td><td colspan="1" rowspan="1">Data Analysis is performed byinstrument embedded software</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="3" rowspan="1">Differences</td></tr><tr><td colspan="1" rowspan="1">Item</td><td colspan="1" rowspan="1">DeviceK161816</td><td colspan="1" rowspan="1">PredicateK903505</td></tr><tr><td colspan="1" rowspan="1">Instrument</td><td colspan="1" rowspan="1">BacT/ALERT VIRTUOMicrobial Detection System</td><td colspan="1" rowspan="1">BacT/ALERT 3D MicrobialDetection System</td></tr><tr><td colspan="1" rowspan="1">Indicated BottleTypes</td><td colspan="1" rowspan="1">FA Plus, FN Plus, PF Plus,SA, and SN culture bottles</td><td colspan="1" rowspan="1">Same, in addition to FA, FNand MP culture bottles</td></tr><tr><td colspan="1" rowspan="1">Capacity</td><td colspan="1" rowspan="1">108-6912 bottles</td><td colspan="1" rowspan="1">240-1440 bottles</td></tr><tr><td colspan="1" rowspan="1">Bottle Loading</td><td colspan="1" rowspan="1">Automated loading of bottlesplaced on conveyor (up to 40at a time) with bottle labelscanning, measuring ofsample volume &amp; loading viarobotic arm into openincubator cell with appropriateagitation. Customer canmanually load bottles ifautomation features are not</td><td colspan="1" rowspan="1">Customer scans bottle labelsand loads the bottle into abottle cell of an open drawer,one bottle at a time</td></tr><tr><td colspan="1" rowspan="1">Bottle Unloading</td><td colspan="1" rowspan="1">Bottles unloadedautomatically via a roboticarm</td><td colspan="1" rowspan="1">Bottles manually unloadedone at a time</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

1. Clinical and Laboratory Standards Institute(CLSI): Principles and procedures for blood cultures M47-A, Vol. 27, No 17

2. ISO 15223-1:2012 Medical Devices - Symbols to be Used with Medical Device Labels, Labeling and Information to be Supplied

3. EN 61010-1: 2010 Safety Requirements for Electrical Equipment for Measurement, Control and Laboratory Use Part 1: General Requirements Part 1: General Requirements

4. IEC 62366:2007 Medical Devices - Application of Usability Engineering to Medical Devices

# L. Test Principle:

The VIRTUO system utilizes a colorimetric sensor and reflected light to monitor the presence and production of carbon dioxide $\left( \mathrm { C O } _ { 2 } \right)$ dissolved in the culture medium. If microorganisms are present in the inoculated sample, carbon dioxide is produced as the organisms metabolize the substrates in the culture medium. When growth of the microorganisms produces $\mathrm { C O } _ { 2 }$ , the color of the gas-permeable sensor installed in the bottom of each culture bottle changes from blue-green to yellow. The color change results in an increase of reflectance units monitored by the system. VIRTUO optically monitors the reflectance of each bottle over time and will store and interpret readings against algorithms, which are embedded in the firmware and/or software.

# M. Performance Characteristics:

# 1. Analytical performance:

Note: FA Plus and PF Plus culture bottles are identical except for bottle labeling and recommended specimen volume. In addition, the detection algorithms for VIRTUO and BTA 3D are the same for both bottle types. Therefore PF Plus bottles were not evaluated in analytical studies and results from FA Plus bottles were used to support analytical performance of PF plus bottles on VIRTUO.

# a. Precision/Reproducibility

# Reproducibility Study

The reproducibility of the VIRTUO System was evaluated using six representative organisms of the most common pathogens associated with blood stream infections. The study was performed at three sites (1 internal and 2 external). One or more operators at each site performed two runs per day with two lots of FA Plus culture bottles over five days of testing for a total of 90 culture bottles tested at each clinical site for a total of 270 seeded bottles. Additionally, 48 negative control bottles containing only blood were evaluated. For calculation of percent recovery, positive results reflect a positive flag by the instrument and Gram stain/subculture consistent with the seeded organism.

The organisms evaluated and concentrations used for bottle inoculation are shown in Table 1.

Table 1: Reproducibility Study Organisms   

<table><tr><td rowspan=1 colspan=1>Microorganism</td><td rowspan=1 colspan=1>Inoculum,Concentration</td><td rowspan=1 colspan=1>Microorganism</td><td rowspan=1 colspan=1>InoculumConcentration</td></tr><tr><td rowspan=1 colspan=1>Staphylococcusaureus</td><td rowspan=1 colspan=1>~30 CFU/bottle</td><td rowspan=1 colspan=1>Pseudomonasaeruginosa</td><td rowspan=1 colspan=1>~30 CFU/bottle</td></tr><tr><td rowspan=1 colspan=1>Candida albicans</td><td rowspan=1 colspan=1>~100 CFU/bottle</td><td rowspan=1 colspan=1>Haemophilusinfluenzae</td><td rowspan=1 colspan=1>~100 CFU/bottle</td></tr><tr><td rowspan=1 colspan=1>Escherichia coli</td><td rowspan=1 colspan=1>~30 CFU/bottle</td><td rowspan=1 colspan=1>Streptococcuspneumoniae</td><td rowspan=1 colspan=1>~100 CFU/bottle</td></tr></table>

The reproducibility study demonstrated that the VIRTUO instrument generated $100 \%$ positive results for all FA Plus bottles evaluated. In addition, $100 \%$ of negative control bottles were reported as negative by the instrument. Study results are shown in Table

Table 2: Reproducibility Study Results   

<table><tr><td rowspan=2 colspan=1>Organism</td><td rowspan=1 colspan=4>% Recovery (# detected/# tested), [95% Cl]</td><td rowspan=1 colspan=2>Time to Detection(hours)</td></tr><tr><td rowspan=1 colspan=1>Site 1</td><td rowspan=1 colspan=1>Site2</td><td rowspan=1 colspan=1>Site3</td><td rowspan=1 colspan=1>Overall</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Range</td></tr><tr><td rowspan=1 colspan=1>Staphylococcusaureus</td><td rowspan=1 colspan=1>100.0%(15/15)</td><td rowspan=1 colspan=1>100.0%(15/15)</td><td rowspan=1 colspan=1>100.0%(15/15)</td><td rowspan=1 colspan=1>100.0%(45/45)[92.1·100.0]</td><td rowspan=1 colspan=1>12.43</td><td rowspan=1 colspan=1>11.93 - 13.37</td></tr><tr><td rowspan=1 colspan=1>Candida albicans</td><td rowspan=1 colspan=1>100.0%(15/15)</td><td rowspan=1 colspan=1>100.0%(15/15)</td><td rowspan=1 colspan=1>100.0%(15/15)</td><td rowspan=1 colspan=1>100.0%(45/45)[92.1·100.0]</td><td rowspan=1 colspan=1>27.64</td><td rowspan=1 colspan=1>27.64 20.20- 38.83</td></tr><tr><td rowspan=1 colspan=1>E. coli</td><td rowspan=1 colspan=1>100.0%(15/15)</td><td rowspan=1 colspan=1>100.0%(15/15)</td><td rowspan=1 colspan=1>100.0%(15/15)</td><td rowspan=1 colspan=1>100.0%(45/45)[92.1·100.0]</td><td rowspan=1 colspan=1>8.62</td><td rowspan=1 colspan=1>8.10-9.25</td></tr><tr><td rowspan=1 colspan=1>Pseudomonas aeruginosa</td><td rowspan=1 colspan=1>100.0%(15/15)</td><td rowspan=1 colspan=1>100.0%(15/15)</td><td rowspan=1 colspan=1>100.0%(15/15)</td><td rowspan=1 colspan=1>100.0%(45/45)[92.1·100.0]</td><td rowspan=1 colspan=1>14.06</td><td rowspan=1 colspan=1>13.27-15.65</td></tr><tr><td rowspan=1 colspan=1>Haemophilus influenzae</td><td rowspan=1 colspan=1>100.0%15/15)</td><td rowspan=1 colspan=1>100.0%(15/15)</td><td rowspan=1 colspan=1>100.0%15/15)</td><td rowspan=1 colspan=1>100.0%(45/45)[92.1·100.0]</td><td rowspan=1 colspan=1>14.02</td><td rowspan=1 colspan=1>11.64-17.31</td></tr><tr><td rowspan=1 colspan=1>S. pneumoniae</td><td rowspan=1 colspan=1>100.0%(15/15)</td><td rowspan=1 colspan=1>100.0%(15/15)</td><td rowspan=1 colspan=1>100.0%(15/15)</td><td rowspan=1 colspan=1>100.0%(45/45)[92.1·100.0]</td><td rowspan=1 colspan=1>12.07</td><td rowspan=1 colspan=1>10.86-13.59</td></tr><tr><td rowspan=1 colspan=1>Negative Control</td><td rowspan=1 colspan=1>0%(0/15)</td><td rowspan=1 colspan=1>0%(0/15)</td><td rowspan=1 colspan=1>0%(0/15)</td><td rowspan=1 colspan=1>0%(0/45)</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr></table>

# Within-Laboratory Precision Study

Testing was conducted with FA Plus, FN Plus, SA and SN culture bottles in an inhouse precision study for 20 days using multiple VIRTUO instruments and multiple operators. Three bottle replicates per organism, instrument, bottle type and bottle lot were tested for a minimum of 60 bottles tested for each organism and bottle lot. The target organism inoculum was less than 30 CFU/bottle. Bottles were tested without blood except for $1 \mathrm { m L }$ of added blood for bottles spiked with $B .$ . fragilis and $S .$ . pneumoniae and $4 \mathrm { m L }$ of added blood for bottles spiked with $H .$ influenzae. The rate of detection and recovery as well as the mean time to detection was calculated for each organism and bottle type evaluated. For calculation of percent recovery, positive results reflect a positive flag by the instrument and Gram stain/subculture consistent with the seeded organism.

The within-laboratory precision study results were acceptable. Results are shown in Tables 3-6 for FA Plus, FN Plus, SA and SN culture bottles, respectively.

Table 3. FA Plus Bottles: Within-Laboratory Precision   

<table><tr><td rowspan=1 colspan=1>Sample Input</td><td rowspan=2 colspan=1>Range(CFU/bottle)</td><td rowspan=1 colspan=4>% Recovery (# detected/# tested)</td><td rowspan=1 colspan=2>Time to Detection(hours)</td></tr><tr><td rowspan=1 colspan=1>Organism</td><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>Overall</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Range</td></tr><tr><td rowspan=1 colspan=1>Candida albicans</td><td rowspan=1 colspan=1>3-30</td><td rowspan=1 colspan=1>100(141/141)</td><td rowspan=1 colspan=1>100(144/144)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(345/345)</td><td rowspan=1 colspan=1>27.1</td><td rowspan=1 colspan=1>21.4-40.0</td></tr><tr><td rowspan=1 colspan=1>Enterococcusfaecalis</td><td rowspan=1 colspan=1>3-16</td><td rowspan=1 colspan=1>100(162/162)</td><td rowspan=1 colspan=1>100(162/162)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(384/384)</td><td rowspan=1 colspan=1>10.9</td><td rowspan=1 colspan=1>9.6-12.4</td></tr><tr><td rowspan=1 colspan=1>Escherichia coli</td><td rowspan=1 colspan=1>8-20</td><td rowspan=1 colspan=1>100(153/153)</td><td rowspan=1 colspan=1>100(153/153)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(366/366)</td><td rowspan=1 colspan=1>9.6</td><td rowspan=1 colspan=1>8.7-10.8</td></tr><tr><td rowspan=1 colspan=1>Haemophilusinfluenzae*</td><td rowspan=1 colspan=1>1-24</td><td rowspan=1 colspan=1>100(162/162)</td><td rowspan=1 colspan=1>100(162/162)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(384/384)</td><td rowspan=1 colspan=1>13.6</td><td rowspan=1 colspan=1>11.0-21.6</td></tr><tr><td rowspan=1 colspan=1>Pseudomonasaeruginosa</td><td rowspan=1 colspan=1>5-17</td><td rowspan=1 colspan=1>100(162/162)</td><td rowspan=1 colspan=1>100(162/162)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(384/384)</td><td rowspan=1 colspan=1>14.7</td><td rowspan=1 colspan=1>12.8-17.6</td></tr><tr><td rowspan=1 colspan=1>Staphylococcusaureus</td><td rowspan=1 colspan=1>5-16</td><td rowspan=1 colspan=1>100(171/171)</td><td rowspan=1 colspan=1>100(171/171)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(402/402)</td><td rowspan=1 colspan=1>12.7</td><td rowspan=1 colspan=1>11.5-15.0</td></tr><tr><td rowspan=1 colspan=1>Streptococcus**pneumoniae*</td><td rowspan=1 colspan=1>1-29</td><td rowspan=1 colspan=1>100(162/162)</td><td rowspan=1 colspan=1>100(162/162)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(384/384)</td><td rowspan=1 colspan=1>12.0</td><td rowspan=1 colspan=1>9.6-15.6</td></tr></table>

\*Tested with 4 mL blood. \*\*Tested with 1 mL blood.

Table 4. FN Plus Bottles: Within-Laboratory Precision   

<table><tr><td rowspan=1 colspan=1>Sample Input</td><td rowspan=2 colspan=1>Range(CFU/bottle)</td><td rowspan=1 colspan=4>% Recovery (# detected/# tested)</td><td rowspan=1 colspan=2>Time to Detection(hours)</td></tr><tr><td rowspan=1 colspan=1>Organism</td><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>Overall</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Range</td></tr><tr><td rowspan=1 colspan=1>Bacteroidesfragilis*</td><td rowspan=1 colspan=1>4-33</td><td rowspan=1 colspan=1>100(162/162)</td><td rowspan=1 colspan=1>100(163/163)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(385/385)</td><td rowspan=1 colspan=1>24.5</td><td rowspan=1 colspan=1>21.8-26.7</td></tr><tr><td rowspan=1 colspan=1>Clostridiumperfringens</td><td rowspan=1 colspan=1>4-16</td><td rowspan=1 colspan=1>100(179/180)</td><td rowspan=1 colspan=1>100(177/178)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>99.5(416/418)</td><td rowspan=1 colspan=1>9.9</td><td rowspan=1 colspan=1>8.4-14.5</td></tr><tr><td rowspan=1 colspan=1>Enterococcusfaecalis</td><td rowspan=1 colspan=1>3-16</td><td rowspan=1 colspan=1>100(160/160)</td><td rowspan=1 colspan=1>100(157/157)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(377/377)</td><td rowspan=1 colspan=1>19.9</td><td rowspan=1 colspan=1>18.2-21.8</td></tr><tr><td rowspan=1 colspan=1>Escherichia coli</td><td rowspan=1 colspan=1>4-20</td><td rowspan=1 colspan=1>100(154/154)</td><td rowspan=1 colspan=1>100(153/153)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(367/367)</td><td rowspan=1 colspan=1>9.1</td><td rowspan=1 colspan=1>8.3-10.2</td></tr><tr><td rowspan=1 colspan=1>Staphylococcusaureus</td><td rowspan=1 colspan=1>5-16</td><td rowspan=1 colspan=1>100(171/171)</td><td rowspan=1 colspan=1>100(171/171)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(402/402)</td><td rowspan=1 colspan=1>17.4</td><td rowspan=1 colspan=1>15.4-19.9</td></tr><tr><td rowspan=1 colspan=1>Streptococcuspneumoniae*</td><td rowspan=1 colspan=1>1-29</td><td rowspan=1 colspan=1>100(162/162)</td><td rowspan=1 colspan=1>100(162/162)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(384/384)</td><td rowspan=1 colspan=1>14.5</td><td rowspan=1 colspan=1>12.4-20.2</td></tr></table>

Tested with 1 mL blood.

Table 5. SA Bottles: Within-Laboratory Precision   

<table><tr><td rowspan=2 colspan=1>Organism</td><td rowspan=2 colspan=1>Range(CFU/bottle)</td><td rowspan=1 colspan=4>% Recovery (# detected/# tested)</td><td rowspan=1 colspan=2>Time to Detection(hours)</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>Overall</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Range</td></tr><tr><td rowspan=1 colspan=1>Candida albicans</td><td rowspan=1 colspan=1>10-30</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>98.3(59/60)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>99.4(179/180)</td><td rowspan=1 colspan=1>25.5</td><td rowspan=1 colspan=1>21.0-30.1</td></tr><tr><td rowspan=1 colspan=1>Enterococcusfaecalis</td><td rowspan=1 colspan=1>10-16</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(180/180)</td><td rowspan=1 colspan=1>10.4</td><td rowspan=1 colspan=1>9.5-11.5</td></tr><tr><td rowspan=1 colspan=1>Escherichia coli</td><td rowspan=1 colspan=1>8-15</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(180/180)</td><td rowspan=1 colspan=1>9.8</td><td rowspan=1 colspan=1>8.8-10.9</td></tr><tr><td rowspan=1 colspan=1>Haemophilusinfluenzae*</td><td rowspan=1 colspan=1>14-24</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(180/180)</td><td rowspan=1 colspan=1>17.8</td><td rowspan=1 colspan=1>9.2-23.8</td></tr><tr><td rowspan=1 colspan=1>Pseudomonasaeruginosa</td><td rowspan=1 colspan=1>7-17</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(180/180)</td><td rowspan=1 colspan=1>14.2</td><td rowspan=1 colspan=1>13.0-16.0</td></tr><tr><td rowspan=1 colspan=1>Staphylococcusaureus</td><td rowspan=1 colspan=1>6-11</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(180/180)</td><td rowspan=1 colspan=1>22.3</td><td rowspan=1 colspan=1>15.9-38.2</td></tr><tr><td rowspan=1 colspan=1>Streptococcuspneumoniae**</td><td rowspan=1 colspan=1>6-15</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(180/180)</td><td rowspan=1 colspan=1>14.5</td><td rowspan=1 colspan=1>11.5-20.4</td></tr></table>

\*Tested with 4 mL blood. \*\*Tested with 1 mL blood.

Table 6. SN Bottles: Within-Laboratory Precision   

<table><tr><td rowspan=2 colspan=1>Organism</td><td rowspan=2 colspan=1>Range(CFU/bottle)</td><td rowspan=1 colspan=4>% Recovery (# detected/# tested)</td><td rowspan=1 colspan=2>Time to Detection(hours)</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>Overall</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Range</td></tr><tr><td rowspan=1 colspan=1>Bacteroidesfragilis*</td><td rowspan=1 colspan=1>12-33</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(180/180)</td><td rowspan=1 colspan=1>26.2</td><td rowspan=1 colspan=1>19.7-38.9</td></tr><tr><td rowspan=1 colspan=1>Clostridiumperfringens</td><td rowspan=1 colspan=1>10-15</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(180/180)</td><td rowspan=1 colspan=1>7.9</td><td rowspan=1 colspan=1>6.4-39.7</td></tr><tr><td rowspan=1 colspan=1>Enterococcusfaecalis</td><td rowspan=1 colspan=1>10-16</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(180/180)</td><td rowspan=1 colspan=1>9.9</td><td rowspan=1 colspan=1>9.1-11.0</td></tr><tr><td rowspan=1 colspan=1>Escherichia coli</td><td rowspan=1 colspan=1>8-15</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(180/180)</td><td rowspan=1 colspan=1>8.7</td><td rowspan=1 colspan=1>7.9-9.5</td></tr><tr><td rowspan=1 colspan=1>Staphylococcusaureus</td><td rowspan=1 colspan=1>6-11</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(180/180)</td><td rowspan=1 colspan=1>12.8</td><td rowspan=1 colspan=1>11.3-14.5</td></tr><tr><td rowspan=1 colspan=1>Streptococcuspneumoniae*</td><td rowspan=1 colspan=1>6-15</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(60/60)</td><td rowspan=1 colspan=1>100(180/180)</td><td rowspan=1 colspan=1>14.0</td><td rowspan=1 colspan=1>11.2-17.7</td></tr></table>

Tested with 1 mL blood.

b. Traceability, Stability, Expected values (controls, calibrators, or methods):

# Quality Control

Internal Quality Control:

The VIRTUO system is designed with internal quality control/calibration. This is accomplished by automated comparison of optical readings to Reflectance Calibration Standards that reside in the VIRTUO instrument.

External Quality Control:

During the clinical study, daily external quality control was conducted on the VIRTUO system and included one positive and one negative control bottle for each bottle type tested. Control organisms were seeded into bottles at target inoculum levels of approximately 30 CFU/bottle. Organism concentrations for bottle seeding were confirmed by plate counting procedures. For aerobic bottles, organisms evaluated included one obligate aerobe (Pseudomonas aeruginosa) and one facultative organism (Escherichia coli). For anaerobic bottles, organisms evaluated included one obligate anaerobe (Clostridium perfringens) and one facultative organism (Escherichia coli). For each bottle type, one organism was evaluated daily, alternating between the quality control two organisms. In addition, an uninoculated negative control bottle was tested daily for each bottle type. There were 1490 positive controls tested on VIRTUO for all clinical sites combined. Of those, 1487 $( 9 9 . 8 \% )$ generated the expected positive signal by VIRTUO. There were 1486 negative controls tested on VIRTUO for all sites combined and $100 \%$ were reported as negative.

# c. Limit of Detection

The Limit of Detection (LoD) for FA Plus, FN Plus, SA and SN bottles was evaluated for bottles incubated on VIRTUO. The LoD for FA Plus and FN Plus was evaluated only on VIRTUO and compared to the LoD established previously on BTA 3D during studies performed for bottle clearance (i.e., K121461, K121455, K121446). The LoDs for SA and SN bottles had not been established on the BTA 3D; therefore LoD testing for SA and SN bottles was performed on both instrument systems. Because the media formulations are the same for FA Plus and PF Plus bottles, the LoD for FA Plus bottles is also claimed for PF Plus bottles.

Concentrations of organism suspensions used for bottle inoculation were determined by plating and colony counts. Each bottle was inoculated with organism suspensions prepare to yield 5 CFU/bottle. To support growth, human blood was added to bottles inoculated with B. fragilis, S. pneumoniae, and H. influenzae. Bottles were incubated on VIRTUO and BTA 3D instruments until flagged as positive. All bottles were subcultured and evaluated for growth, purity and presence of the appropriate test organism.

A total of 60 replicates were tested for each bottle type/microorganism combination (ten replicates for each of three bottle lots, tested on two VIRTUO instruments). Additionally, a total of 30 replicates were tested on one BTA 3D instrument for each SA and SN bottle type/microorganism combination.

The LoD for each organism/bottle type/instrument was determined to be the organism concentration (CFU/bottle) for which $9 5 \%$ of bottles were flagged positive by the instrument and were also positive by subculture. The LoDs for the organisms

evaluated in each bottle type are shown in Tables 7 for testing on VIRTUO and Table 8 for testing on BTA 3D.

Table 7. Organism LoD (CFU/Bottle) on VIRTUO   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=4>CFU/Bottle</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>FA Plus/PF Plus</td><td rowspan=1 colspan=1>SA</td><td rowspan=1 colspan=1>FN Plus</td><td rowspan=1 colspan=1>SN</td></tr><tr><td rowspan=1 colspan=1>Candida albicans</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>E. faecalis</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>3</td></tr><tr><td rowspan=1 colspan=1>E. coli</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>4</td></tr><tr><td rowspan=1 colspan=1>H. influenzae*</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>P. aeruginosa</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>S. aureus</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>6</td></tr><tr><td rowspan=1 colspan=1>S. pneumoniae*</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>5</td></tr><tr><td rowspan=1 colspan=1>B. fragilis**</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>4</td></tr><tr><td rowspan=1 colspan=1>C. perfringens</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>4</td></tr></table>

\* 1 mL blood added \*\* 4 mL blood added

Table 8. Organism LoD (CFU/bottle) on BTA 3D   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=4>CFU/Bottle</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>FA Plus/PF Plus***</td><td rowspan=1 colspan=1>SA</td><td rowspan=1 colspan=1>FNPlus***</td><td rowspan=1 colspan=1>SN</td></tr><tr><td rowspan=1 colspan=1>Aspergillus brasiliensis</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Candida albicans</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>E. faecalis</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>3</td></tr><tr><td rowspan=1 colspan=1>E. coli</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>4</td></tr><tr><td rowspan=1 colspan=1>H. influenzae*</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>P. aeruginosa</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>S. aureus</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>6</td></tr><tr><td rowspan=1 colspan=1>S. pneumoniae*</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>5</td></tr><tr><td rowspan=1 colspan=1>B. fragilis**</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>4</td></tr><tr><td rowspan=1 colspan=1>C. perfringens</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>4</td></tr></table>

\* 1 mL blood added \*\* 4 mL blood added \*\*\* Note: LoD values determined previously for initial bottle clearance (K121461, K121455, K121446).

# d. Comparison Panel Growth Performance Study

The performance of the VIRTUO and BTA 3D systems were compared in an analytical study using a panel of microorganisms seeded into FA Plus, FN Plus, SA, and SN bottles. The growth performance study was conducted internally with seeded bottles containing two different blood volumes (4 and $1 0 ~ \mathrm { m L }$ ). Seeded bottles without blood were also evaluated. A single strain was tested for each species evaluated at target inoculum levels of $\leq 3 0$ CFU/bottle. Each microorganism was tested in triplicate for each bottle type and blood level on three VIRTUO systems for a total of 27 bottles per organism/bottle type. For BTA 3D, 9 bottles per blood level were tested on one system for a total of 27 bottles per organism and bottle type. Two positive bottles were subcultured per organism and per bottle type to assess for purity. All seeded bottles that were declared negative by the instrument(s) were subcultured.

Tables 9 and 10 list the strains evaluated for the aerobic and anaerobic bottles in the Comparison Panel Growth Performance Study.

Table 9: Comparison Panel of Organisms for Aerobic Blood Culture Bottle (FA Plus and SA)   

<table><tr><td rowspan=1 colspan=1>Microorganism</td><td rowspan=1 colspan=1>ATCC #</td><td rowspan=1 colspan=1>Microorganism</td><td rowspan=1 colspan=1>ATCC #</td></tr><tr><td rowspan=1 colspan=1>Abiotrophia defectiva</td><td rowspan=1 colspan=1>9497</td><td rowspan=1 colspan=1>Micrococcus luteus</td><td rowspan=1 colspan=1>4698</td></tr><tr><td rowspan=1 colspan=1>Aggregatibacteractinomycetemcomitans</td><td rowspan=1 colspan=1>29523</td><td rowspan=1 colspan=1>Neisseria meningitidis</td><td rowspan=1 colspan=1>13090</td></tr><tr><td rowspan=1 colspan=1>Campylobacter jejuni</td><td rowspan=1 colspan=1>33291</td><td rowspan=1 colspan=1>Proteus vulgaris</td><td rowspan=1 colspan=1>8427</td></tr><tr><td rowspan=1 colspan=1>Candida albicans</td><td rowspan=1 colspan=1>14053</td><td rowspan=1 colspan=1>Pseudomonas aeruginosa</td><td rowspan=1 colspan=1>27853</td></tr><tr><td rowspan=1 colspan=1>Candida glabrata</td><td rowspan=1 colspan=1>66032</td><td rowspan=1 colspan=1>Salmonella enterica</td><td rowspan=1 colspan=1>14028</td></tr><tr><td rowspan=1 colspan=1>Candida krusei</td><td rowspan=1 colspan=1>14243</td><td rowspan=1 colspan=1>Serratia marcescens</td><td rowspan=1 colspan=1>33949</td></tr><tr><td rowspan=1 colspan=1>Cardiobacterium hominis</td><td rowspan=1 colspan=1>500276</td><td rowspan=1 colspan=1>Staphylococcus aureus</td><td rowspan=1 colspan=1>25923</td></tr><tr><td rowspan=1 colspan=1>Corynebacterium jeikeium</td><td rowspan=1 colspan=1>14124</td><td rowspan=1 colspan=1>Staphylococcus epidermidis</td><td rowspan=1 colspan=1>12228</td></tr><tr><td rowspan=1 colspan=1>Cryptococcus neoformans</td><td rowspan=1 colspan=1>14116</td><td rowspan=1 colspan=1>Stenotrophomonas maltophilia</td><td rowspan=1 colspan=1>13637</td></tr><tr><td rowspan=1 colspan=1>Eikenella corrodens</td><td rowspan=1 colspan=1>102025</td><td rowspan=1 colspan=1>Streptococcus agalactiae</td><td rowspan=1 colspan=1>13813</td></tr><tr><td rowspan=1 colspan=1>Enterobacter aerogenes</td><td rowspan=1 colspan=1>13048</td><td rowspan=1 colspan=1>Streptococcus mitis</td><td rowspan=1 colspan=1>15914</td></tr><tr><td rowspan=1 colspan=1>Enterococcus faecalis</td><td rowspan=1 colspan=1>29212</td><td rowspan=1 colspan=1>Streptococcus pneumoniae</td><td rowspan=1 colspan=1>6305</td></tr><tr><td rowspan=1 colspan=1>Escherichia coli</td><td rowspan=1 colspan=1>25922</td><td rowspan=1 colspan=1>Streptococcus pyogenes</td><td rowspan=1 colspan=1>19615</td></tr><tr><td rowspan=1 colspan=1>Haemophilus influenzae</td><td rowspan=1 colspan=1>10211</td><td rowspan=3 colspan=2></td></tr><tr><td rowspan=1 colspan=1>Klebsiella pneumoniae</td><td rowspan=1 colspan=1>35657</td></tr><tr><td rowspan=1 colspan=1>Listeria monocytogenes</td><td rowspan=1 colspan=1>15313</td></tr></table>

Table 10: Comparison Panel of Organisms for Anaerobic Blood Culture Bottles (FN Plus and SN)   

<table><tr><td rowspan=1 colspan=1>Microorganism</td><td rowspan=1 colspan=1>ATCC #</td><td rowspan=1 colspan=1>Microorganism</td><td rowspan=1 colspan=1>ATCC #</td></tr><tr><td rowspan=1 colspan=1>Bacteroides fragilis</td><td rowspan=1 colspan=1>25285</td><td rowspan=1 colspan=1>Escherichia coli</td><td rowspan=1 colspan=1>25922</td></tr><tr><td rowspan=1 colspan=1>Bacteroides thetaiotaomicron</td><td rowspan=1 colspan=1>29741</td><td rowspan=1 colspan=1>Fusobacterium nucleatum</td><td rowspan=1 colspan=1>25586</td></tr><tr><td rowspan=1 colspan=1>Bacteroides vulgatus</td><td rowspan=1 colspan=1>8482</td><td rowspan=1 colspan=1>Parvimonas micra</td><td rowspan=1 colspan=1>33270</td></tr><tr><td rowspan=1 colspan=1>Clostridium perfringens</td><td rowspan=1 colspan=1>13124</td><td rowspan=1 colspan=1>Peptoniphilus asaccharolyticus</td><td rowspan=1 colspan=1>14963</td></tr><tr><td rowspan=1 colspan=1>Clostridium septicum</td><td rowspan=1 colspan=1>400013</td><td rowspan=1 colspan=1>Staphylococcus aureus</td><td rowspan=1 colspan=1>25923</td></tr><tr><td rowspan=1 colspan=1>Eggerthella lenta</td><td rowspan=1 colspan=1>25559</td><td rowspan=1 colspan=1>Streptococcus pneumoniae</td><td rowspan=1 colspan=1>6305</td></tr><tr><td rowspan=1 colspan=1>Enterococcus faecalis</td><td rowspan=1 colspan=1>29212</td><td rowspan=1 colspan=1>Streptococcus pyogenes</td><td rowspan=1 colspan=1>19615</td></tr></table>

formance Summary without Blood (0 Tables 11-18 include stratified results for FA Plus, FN Plus, SA and SN bottles, tested either with blood or without blood added. For each bottle type, bottles were seeded with applicable organisms and incubated/monitored on both VIRTUO and No BloBTA 3D systems.

Table 11: FA Plus Bottles: Growth Performance on BacT/ALERT VIRTUO and   

<table><tr><td colspan="9" rowspan="1">on BacT7ALERT 3D in Bottles Tested with Blood</td></tr><tr><td colspan="1" rowspan="2">Organism</td><td colspan="4" rowspan="1">FA Plus BacT/ALERT VIRTUO WithBlood</td><td colspan="4" rowspan="1">FA Plus BacT/ALERT 3D With Blood</td></tr><tr><td colspan="1" rowspan="1">%Recovery*()</td><td colspan="1" rowspan="1">AverageC F/Bottle</td><td colspan="1" rowspan="1">MeanTTD</td><td colspan="1" rowspan="1">RangeTTD </td><td colspan="1" rowspan="1">%Recovery*(n)</td><td colspan="1" rowspan="1">AverageCFU/bottle</td><td colspan="1" rowspan="1">MeanTTD</td><td colspan="1" rowspan="1">RangeTTD</td></tr><tr><td colspan="1" rowspan="1">Abiotrophiadefectiva</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">15.1</td><td colspan="1" rowspan="1">14.2-16.1</td><td colspan="1" rowspan="1">100.0(12/12)</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">22.0</td><td colspan="1" rowspan="1">19.0-28.6</td></tr><tr><td colspan="1" rowspan="1">Aggregatibacteractinomycetemcomitans</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">30.4</td><td colspan="1" rowspan="1">22.2-36.2</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">34.8</td><td colspan="1" rowspan="1">28.1-39.8</td></tr><tr><td colspan="1" rowspan="1">Campylobacterjejuni</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">40.2</td><td colspan="1" rowspan="1">34.2-50.2</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">44.6</td><td colspan="1" rowspan="1">37.7-54.5</td></tr><tr><td colspan="1" rowspan="1">Candida albicans</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">27.0</td><td colspan="1" rowspan="1">23.4-29.8</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">28.5</td><td colspan="1" rowspan="1">26.6-31.7</td></tr><tr><td colspan="1" rowspan="1">Candida glabrata</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">45.5</td><td colspan="1" rowspan="1">38.4-57.2</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">50.4</td><td colspan="1" rowspan="1">45.6-55.9</td></tr><tr><td colspan="1" rowspan="1">Candida krusei</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">17.1</td><td colspan="1" rowspan="1">16.1-17.9</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19.1</td><td colspan="1" rowspan="1">18.7-19.7</td></tr><tr><td colspan="1" rowspan="1">Cardiobacteriumhominis</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">45.6</td><td colspan="1" rowspan="1">39.7-52.4</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">57.6</td><td colspan="1" rowspan="1">50.9-65.5</td></tr><tr><td colspan="1" rowspan="1">Corynebacteriumjeikeium</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">34.7</td><td colspan="1" rowspan="1">28.2-50.7</td><td colspan="1" rowspan="1">100.0(17/17)</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">68.6</td><td colspan="1" rowspan="1">48.5-112.8</td></tr><tr><td colspan="1" rowspan="1">Cryptococcusneoformans</td><td colspan="1" rowspan="1">100.0(16/16)</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">56.1</td><td colspan="1" rowspan="1">20.7-67.4</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">57.6</td><td colspan="1" rowspan="1">54.2-59.5</td></tr><tr><td colspan="1" rowspan="1">Eikenellacorrodens</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">22.2</td><td colspan="1" rowspan="1">20.1-23.6</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">25.3</td><td colspan="1" rowspan="1">24.0-26.6</td></tr><tr><td colspan="1" rowspan="1">Enterobacteraerogenes</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">11.3</td><td colspan="1" rowspan="1">10.3-13.0</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">12.7</td><td colspan="1" rowspan="1">12.0-13.4</td></tr><tr><td colspan="1" rowspan="1">Enterococcusfecalis</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">10.3</td><td colspan="1" rowspan="1">9.4-11.0</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">12.3</td><td colspan="1" rowspan="1">12.0-13.0</td></tr><tr><td colspan="1" rowspan="1">Escherichia coli</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">9.3</td><td colspan="1" rowspan="1">8.6-10.1</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">11.1</td><td colspan="1" rowspan="1">9.1-11.8</td></tr><tr><td colspan="1" rowspan="1">Haemophilusinfluenzae</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">14.1</td><td colspan="1" rowspan="1">9.1-16.3</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">17.6</td><td colspan="1" rowspan="1">16.6-18.5</td></tr><tr><td colspan="1" rowspan="1">Klebsiellapneumoniae</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">9.7</td><td colspan="1" rowspan="1">8.8-10.4</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">11.9</td><td colspan="1" rowspan="1">11.5-12.2</td></tr><tr><td colspan="1" rowspan="1">Listeriamonocytogenes</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">19.7</td><td colspan="1" rowspan="1">18.2-21.3</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20.8</td><td colspan="1" rowspan="1">20.2-21.6</td></tr><tr><td colspan="1" rowspan="1">Micrococcus luteus</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">32.7</td><td colspan="1" rowspan="1">30.0-36.1</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">34.7</td><td colspan="1" rowspan="1">32.4-37.7</td></tr><tr><td colspan="1" rowspan="1">Neisseriameninitidis</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">20.4</td><td colspan="1" rowspan="1">18.0-23.8</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">22.4</td><td colspan="1" rowspan="1">20.4-25.0</td></tr><tr><td colspan="1" rowspan="1">Proteus vulgaris</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">11.8</td><td colspan="1" rowspan="1">11.0-12.5</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">13.6</td><td colspan="1" rowspan="1">13.2-13.9</td></tr><tr><td colspan="1" rowspan="1">Pseudomonasaeruginosa</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">14.4</td><td colspan="1" rowspan="1">13.8-15.2</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">16.8</td><td colspan="1" rowspan="1">16.3-18.0</td></tr><tr><td colspan="1" rowspan="1">Salmonellaenterica</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">11.5</td><td colspan="1" rowspan="1">10.6-12.5</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">13.6</td><td colspan="1" rowspan="1">12.5-15.1</td></tr><tr><td colspan="1" rowspan="1">Serratiamarcescens</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">11.4</td><td colspan="1" rowspan="1">10.7-12.3</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">13.2</td><td colspan="1" rowspan="1">12.5-14.2</td></tr><tr><td colspan="1" rowspan="1">Staphylococcusaureus</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">10.7</td><td colspan="1" rowspan="1">10.1-11.5</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">13.2</td><td colspan="1" rowspan="1">12.7-13.9</td></tr><tr><td colspan="1" rowspan="2">Organism</td><td colspan="4" rowspan="1">FA Plus BacT/ALERT VIRTUO WithBlood</td><td colspan="4" rowspan="1">FA Plus BacT/ALERT 3D With Blood</td></tr><tr><td colspan="1" rowspan="1">%Recovery*(n)</td><td colspan="1" rowspan="1">AverageCFU/Bottle</td><td colspan="1" rowspan="1">MeanTTD</td><td colspan="1" rowspan="1">RangeTTD</td><td colspan="1" rowspan="1">%Recovery*(n)</td><td colspan="1" rowspan="1">AverageCFU/bottle</td><td colspan="1" rowspan="1">MeanTTD</td><td colspan="1" rowspan="1">RangeTTD</td></tr><tr><td colspan="1" rowspan="1">Staphylococcusepidermidis</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">15.9</td><td colspan="1" rowspan="1">14.1-18.0</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">17.7</td><td colspan="1" rowspan="1">16.6-18.7</td></tr><tr><td colspan="1" rowspan="1">Stenotrophomonasmaltophilia</td><td colspan="1" rowspan="1">100.0(16/16)</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">54.0</td><td colspan="1" rowspan="1">24.8-83.9</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">31.9</td><td colspan="1" rowspan="1">27.6-37.0</td></tr><tr><td colspan="1" rowspan="1">Streptococcusagalactiae</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">11.9</td><td colspan="1" rowspan="1">10.5-13.3</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">15.0</td><td colspan="1" rowspan="1">13.9-16.1</td></tr><tr><td colspan="1" rowspan="1">Streptococcus mitis</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">17</td><td colspan="1" rowspan="1">9.3</td><td colspan="1" rowspan="1">8.6-10.4</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">17</td><td colspan="1" rowspan="1">11.7</td><td colspan="1" rowspan="1">11.3-12.0</td></tr><tr><td colspan="1" rowspan="1">Streptococcuspneumoniae</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">11.4</td><td colspan="1" rowspan="1">10.6-12.1</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">13.7</td><td colspan="1" rowspan="1">13.4-14.2</td></tr><tr><td colspan="1" rowspan="1">Streptococcuspyogenes</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">10.4</td><td colspan="1" rowspan="1">9.8-10.9</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">12.4</td><td colspan="1" rowspan="1">11.5-13.0</td></tr></table>

\*Percent Recovery $=$ #detected/#tested

Table 12. FA Plus Bottles: Growth Performance on BacT/ALERT VIRTUO and on BacT/ALERT 3D in Bottles Tested with No Blood   

<table><tr><td colspan="1" rowspan="2">Organism</td><td colspan="4" rowspan="1">FA Plus BacT/ALERT VIRTUO No Blood</td><td colspan="4" rowspan="1">FA Plus BacT/ALERT 3D No Blood</td></tr><tr><td colspan="1" rowspan="1">%Recovery*(n)</td><td colspan="1" rowspan="1">AverageCFU/Bottle</td><td colspan="1" rowspan="1">MeanTTD</td><td colspan="1" rowspan="1">RangeTTD</td><td colspan="1" rowspan="1">%Recovery*(n)</td><td colspan="1" rowspan="1">AverageCFU/bottle</td><td colspan="1" rowspan="1">MeanTTD</td><td colspan="1" rowspan="1">RangeTTD</td></tr><tr><td colspan="1" rowspan="1">Abiotrophiadefectiva</td><td colspan="1" rowspan="1">100.0(3/3)</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">34.6</td><td colspan="1" rowspan="1">27.8-41.8</td><td colspan="1" rowspan="1">100.0(5/5)</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">32.5</td><td colspan="1" rowspan="1">25.4-47.5</td></tr><tr><td colspan="1" rowspan="1">Aggregatibacteractinomycetemcomitans</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">30.3</td><td colspan="1" rowspan="1">27.8-32.2</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">36.2</td><td colspan="1" rowspan="1">32.9-43.2</td></tr><tr><td colspan="1" rowspan="1">Campylobacterjejuni</td><td colspan="1" rowspan="1">100.0(6/6)</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">45.8</td><td colspan="1" rowspan="1">40.2-52.0</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">49.2</td><td colspan="1" rowspan="1">47.3-51.4</td></tr><tr><td colspan="1" rowspan="1">Candida albicans</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">25.9</td><td colspan="1" rowspan="1">24.3-28.1</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">29.1</td><td colspan="1" rowspan="1">27.4-32.4</td></tr><tr><td colspan="1" rowspan="1">Candida glabrata</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">52.5</td><td colspan="1" rowspan="1">35.7-64.7</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">69.4</td><td colspan="1" rowspan="1">55.9-82.6</td></tr><tr><td colspan="1" rowspan="1">Candida krusei</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20.6</td><td colspan="1" rowspan="1">17.9-22.0</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">22.5</td><td colspan="1" rowspan="1">20.6-24.2</td></tr><tr><td colspan="1" rowspan="1">Cardiobacteriumhominis</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">55.3</td><td colspan="1" rowspan="1">52.8-59.1</td><td colspan="1" rowspan="1">0.0**(0/9)</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">N/A</td><td colspan="1" rowspan="1">N/A</td></tr><tr><td colspan="1" rowspan="1">Cryptococcusneoformans</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">62.6</td><td colspan="1" rowspan="1">54.5-73.4</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">62.8</td><td colspan="1" rowspan="1">58.8-66.5</td></tr><tr><td colspan="1" rowspan="1">Enterobacteraerogenes</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10.2</td><td colspan="1" rowspan="1">9.7-11.7</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">12.9</td><td colspan="1" rowspan="1">12.2-13.2</td></tr><tr><td colspan="1" rowspan="1">Enterococcusfaecalis</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">10.2</td><td colspan="1" rowspan="1">9.4-10.9</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">13.5</td><td colspan="1" rowspan="1">13.2-13.9</td></tr><tr><td colspan="1" rowspan="1">Escherichia coli</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">8.8</td><td colspan="1" rowspan="1">8.3-9.9</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">11.4</td><td colspan="1" rowspan="1">10.8-11.8</td></tr><tr><td colspan="1" rowspan="1">Klebsiellapneumoniae</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">9.7</td><td colspan="1" rowspan="1">9.1-10.9</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">12.3</td><td colspan="1" rowspan="1">12.0-12.5</td></tr><tr><td colspan="1" rowspan="1">Listeriamonocytogenes</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">18.7</td><td colspan="1" rowspan="1">17.2-19.6</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20.2</td><td colspan="1" rowspan="1">19.7-20.9</td></tr><tr><td colspan="1" rowspan="1">Micrococcus luteus</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">31.8</td><td colspan="1" rowspan="1">31.1-33.1</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">35.4</td><td colspan="1" rowspan="1">34.8-36.7</td></tr><tr><td colspan="1" rowspan="1">Proteus vulgaris</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">10.8</td><td colspan="1" rowspan="1">10.2-11.2</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">13.3</td><td colspan="1" rowspan="1">13.0-13.9</td></tr><tr><td colspan="1" rowspan="1">Pseudomonasaeruginosa</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">14.9</td><td colspan="1" rowspan="1">14.1-15.8</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">18.4</td><td colspan="1" rowspan="1">17.8-19.0</td></tr><tr><td colspan="1" rowspan="1">Salmonellaenterica</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">10.4</td><td colspan="1" rowspan="1">10.0-10.9</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">13.3</td><td colspan="1" rowspan="1">12.5-13.9</td></tr><tr><td colspan="1" rowspan="1">Serratiamarcescens</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">11.3</td><td colspan="1" rowspan="1">10.9-12.5</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">13.8</td><td colspan="1" rowspan="1">13.0-15.4</td></tr><tr><td colspan="1" rowspan="1">Staphylococcusaureus</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">12.4</td><td colspan="1" rowspan="1">11.0-13.3</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">15.0</td><td colspan="1" rowspan="1">14.4-16.6</td></tr><tr><td colspan="1" rowspan="1">Staphylococcusepidermidis</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">17.9</td><td colspan="1" rowspan="1">16.4-19.2</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">20.9</td><td colspan="1" rowspan="1">20.4-21.6</td></tr><tr><td colspan="1" rowspan="1">Stenotrophomonasmaltophilia</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">45.0</td><td colspan="1" rowspan="1">31.2-56.9</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">42.7</td><td colspan="1" rowspan="1">33.6-63.8</td></tr><tr><td colspan="1" rowspan="1">Streptococcusagalactiae</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">10.2</td><td colspan="1" rowspan="1">9.9-10.8</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">13.5</td><td colspan="1" rowspan="1">13.2-13.9</td></tr><tr><td colspan="1" rowspan="1">Streptococcus mitis</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">17</td><td colspan="1" rowspan="1">9.0</td><td colspan="1" rowspan="1">8.6-9.8</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">17</td><td colspan="1" rowspan="1">12.6</td><td colspan="1" rowspan="1">12.0-13.7</td></tr><tr><td colspan="1" rowspan="1">Streptococcuspneumoniae</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">10.8</td><td colspan="1" rowspan="1">10.2-11.5</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">13.4</td><td colspan="1" rowspan="1">12.7-14.2</td></tr><tr><td colspan="1" rowspan="1">Streptococcuspyogenes</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">10.5</td><td colspan="1" rowspan="1">10.0-11.9</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">13.0</td><td colspan="1" rowspan="1">12.7-13.4</td></tr></table>

\*Recovery $=$ #detected/#tested $\ast \ast C .$ . hominis was not detected in the absence of blood on the BacT/ALERT 3D (0/9). However, upon subculture of the negative $C .$ . hominis bottles to solid medium, pure growth was observed; therefore these bottles were considered false negative.

NOTE: Recovery of $E$ . corrodens, $H .$ influenzae, C. jeikeium, and $N .$ . meningitidis in FA Plus bottles, tested on either instrument, necessitate blood; therefore, FA Plus bottles not containing blood were excluded from analysis for these organisms. For these organisms, refer to Table 11 above for FA Plus Bottles containing blood.

Table 13. FN Plus Bottles: Growth Performance on BacT/ALERT VIRTUO and on BacT/ALERT 3D in Bottles Tested with Blood   

<table><tr><td rowspan=2 colspan=1>Organism</td><td rowspan=1 colspan=4>FN Plus BacT/ALERT VIRTUO WithBlood</td><td rowspan=1 colspan=4>FN Plus BacT/ALERT 3D With Blood</td></tr><tr><td rowspan=1 colspan=1>%Recovery* (n)</td><td rowspan=1 colspan=1>AverageCFU/Bottle</td><td rowspan=1 colspan=1>MeanTTD</td><td rowspan=1 colspan=1>RangeTTD</td><td rowspan=1 colspan=1>%Recovery*(n)</td><td rowspan=1 colspan=1>AverageCFU/bottle</td><td rowspan=1 colspan=1>MeanTTD</td><td rowspan=1 colspan=1>RangeTTD</td></tr><tr><td rowspan=1 colspan=1>Bacteroides fragilis</td><td rowspan=1 colspan=1>100.0(16/16)</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>30.0</td><td rowspan=1 colspan=1>25.8-36.0</td><td rowspan=1 colspan=1>100.0(15/15)</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>32.5</td><td rowspan=1 colspan=1>27.6-45.6</td></tr><tr><td rowspan=1 colspan=1>Bacteroidesthetaiotaomicron</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>39.9</td><td rowspan=1 colspan=1>32.4-58.9</td><td rowspan=1 colspan=1>100.0(13/13)</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>46.3</td><td rowspan=1 colspan=1>36.7-67.9</td></tr><tr><td rowspan=1 colspan=1>Bacteroidesvulgatus</td><td rowspan=1 colspan=1>100.0(13/13)</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>30.9</td><td rowspan=1 colspan=1>24.1-49.4</td><td rowspan=1 colspan=1>100.0(15/15)</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>31.5</td><td rowspan=1 colspan=1>26.9-34.6</td></tr><tr><td rowspan=1 colspan=1>Clostridiumperfringens</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>27</td><td rowspan=1 colspan=1>9.7</td><td rowspan=1 colspan=1>9.0-11.0</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>27</td><td rowspan=1 colspan=1>12.9</td><td rowspan=1 colspan=1>12.2-14.2</td></tr><tr><td rowspan=1 colspan=1>Clostridiumsepticum</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>11.2</td><td rowspan=1 colspan=1>9.8-14.9</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>15.4</td><td rowspan=1 colspan=1>13.7-22.3</td></tr><tr><td rowspan=1 colspan=1>Eggerthella lenta</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>33.5</td><td rowspan=1 colspan=1>27.9-43.2</td><td rowspan=1 colspan=1>88.9**(16/18)</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>35.0</td><td rowspan=1 colspan=1>32.6-40.1</td></tr><tr><td rowspan=1 colspan=1>Enterococcusfaecalis</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>11.8</td><td rowspan=1 colspan=1>10.5-13.1</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>14.7</td><td rowspan=1 colspan=1>13.0-25.0</td></tr><tr><td rowspan=1 colspan=1>Escherichia coli</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>9.2</td><td rowspan=1 colspan=1>8.6-9.5</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>11.3</td><td rowspan=1 colspan=1>11.0-12.0</td></tr><tr><td rowspan=1 colspan=1>Fusobacteriumnucleatum</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>53.0</td><td rowspan=1 colspan=1>29.3-67.5</td><td rowspan=1 colspan=1>46.2***(6/13)</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>81.0</td><td rowspan=1 colspan=1>43.4-108.5</td></tr><tr><td rowspan=1 colspan=1>Parvimonas micra</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>24</td><td rowspan=1 colspan=1>38.1</td><td rowspan=1 colspan=1>33.9-41.6</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>24</td><td rowspan=1 colspan=1>46.3</td><td rowspan=1 colspan=1>43.9-50.6</td></tr><tr><td rowspan=1 colspan=1>Peptoniphilusasaccharolyticus</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>48.9</td><td rowspan=1 colspan=1>38.8-61.7</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>53.2</td><td rowspan=1 colspan=1>49.2-62.9</td></tr><tr><td rowspan=1 colspan=1>Staphylococcusaureus</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>17.4</td><td rowspan=1 colspan=1>16.0-19.1</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>20.9</td><td rowspan=1 colspan=1>18.5-22.8</td></tr><tr><td rowspan=1 colspan=1>Streptococcuspneumoniae</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>14.2</td><td rowspan=1 colspan=1>12.3-23.0</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>16.4</td><td rowspan=1 colspan=1>15.1-25.4</td></tr><tr><td rowspan=1 colspan=1>Streptococcuspyogenes</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>11.4</td><td rowspan=1 colspan=1>10.1-13.9</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>14.0</td><td rowspan=1 colspan=1>12.0-16.6</td></tr></table>

\*Percent Recovery $=$ #detected/#tested \*\*Two FN Plus bottles spiked with Eggerthella lenta were called negative by BTA 3D. Growth was observed upon subculture; therefore these two bottles were considered false negative. $* * *$ Seven FN Plus bottles spiked with Fusobacterium nucleatum were called negative by BTA 3D. Five of these bottles were subcultured and no growth was observed.

Table 14. FN Plus Bottles: Growth Performance on BacT/ALERT VIRTUO and on BacT/ALERT 3D in Bottles Tested with No Blood   

<table><tr><td rowspan=2 colspan=1>Organism</td><td rowspan=1 colspan=4>FN Plus BacT/ALERT VIRTUO No Blood</td><td rowspan=1 colspan=4>FN Plus BacT/ALERT 3D No Blood</td></tr><tr><td rowspan=1 colspan=1>%Recovery*(n)</td><td rowspan=1 colspan=1>AverageCFU/Bottle</td><td rowspan=1 colspan=1>MeanTTD</td><td rowspan=1 colspan=1>RangeTTD</td><td rowspan=1 colspan=1>%Recovery*(n)</td><td rowspan=1 colspan=1>AverageCFU/Bottle</td><td rowspan=1 colspan=1>MeanTTD</td><td rowspan=1 colspan=1>RangeTTD</td></tr><tr><td rowspan=1 colspan=1>Bacteroides fragilis</td><td rowspan=1 colspan=1>100.0(6/6)</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>39.1</td><td rowspan=1 colspan=1>36.9-44.7</td><td rowspan=1 colspan=1>100.0(10/10)</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>43.4</td><td rowspan=1 colspan=1>39.8-47.3</td></tr><tr><td rowspan=1 colspan=1>Clostridiumperfringens</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>27</td><td rowspan=1 colspan=1>10.1</td><td rowspan=1 colspan=1>8.9-10.9</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>27</td><td rowspan=1 colspan=1>12.5</td><td rowspan=1 colspan=1>12.0-13.0</td></tr><tr><td rowspan=1 colspan=1>Clostridiumsepticum</td><td rowspan=1 colspan=1>100.0(8/8)</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>20.9</td><td rowspan=1 colspan=1>18.6-22.3</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>26.3</td><td rowspan=1 colspan=1>25.7-26.6</td></tr><tr><td rowspan=1 colspan=1>Eggerthella lenta</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>31.2</td><td rowspan=1 colspan=1>27.7-33.9</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>33.4</td><td rowspan=1 colspan=1>31.0-34.8</td></tr><tr><td rowspan=1 colspan=1>Enterococcusfaecalis</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>22.0</td><td rowspan=1 colspan=1>19.6-23.7</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>26.1</td><td rowspan=1 colspan=1>24.5-27.8</td></tr><tr><td rowspan=1 colspan=1>Escherichia coli</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>9.4</td><td rowspan=1 colspan=1>9.0-9.7</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>11.8</td><td rowspan=1 colspan=1>11.3-12.2</td></tr><tr><td rowspan=1 colspan=1>Fusobacteriumnucleatum</td><td rowspan=1 colspan=1>100.0(6/6)</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>69.2</td><td rowspan=1 colspan=1>58.5-83.4</td><td rowspan=1 colspan=1>100.0(5/5)</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>94.0</td><td rowspan=1 colspan=1>73.7-113.5</td></tr><tr><td rowspan=1 colspan=1>Peptoniphilusasaccharolyticus</td><td rowspan=1 colspan=1>100.0(8/8)</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>93.5</td><td rowspan=1 colspan=1>82.6-111.0</td><td rowspan=1 colspan=1>100.0(6/6)</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>94.0</td><td rowspan=1 colspan=1>89.8-99.4</td></tr><tr><td rowspan=1 colspan=1>Staphylococcusaureus</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>21.9</td><td rowspan=1 colspan=1>19.4-26.5</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>22.4</td><td rowspan=1 colspan=1>21.6-23.5</td></tr><tr><td rowspan=1 colspan=1>Streptococcuspneumoniae</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>35.4</td><td rowspan=1 colspan=1>24.3-44.4</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>37.3</td><td rowspan=1 colspan=1>28.6-42.5</td></tr><tr><td rowspan=1 colspan=1>Streptococcuspyogenes</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>31.5</td><td rowspan=1 colspan=1>28.2-34.5</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>35.4</td><td rowspan=1 colspan=1>28.8-41.3</td></tr></table>

\*Percent Recovery $=$ #detected/#tested NOTE: Recovery of $B _ { \cdot }$ . thetaiotaomicron, $B _ { \cdot }$ . vulgatus, and $P .$ . micra in FN Plus bottles, tested on either instrument without blood, did not yield sets of paired data. Therefore, FN Plus bottles not containing blood were excluded from this comparison analysis for these organisms.

Table 15. SA Bottles: Growth Performance on BacT/ALERT VIRTUO and on BacT/ALERT 3D in Bottles Tested with Blood   

<table><tr><td colspan="1" rowspan="2">Organism</td><td colspan="4" rowspan="1">SA BacT/ALERT VIRTUO With Blood</td><td colspan="4" rowspan="1">SA BacT/ALERT 3D With Blood</td></tr><tr><td colspan="1" rowspan="1">%Recovery*(n)</td><td colspan="1" rowspan="1">AverageCFU/Bottle</td><td colspan="1" rowspan="1">MeanTTD</td><td colspan="1" rowspan="1">RangeTTD</td><td colspan="1" rowspan="1">%Recovery*(n)</td><td colspan="1" rowspan="1">AverageCFU/bottle</td><td colspan="1" rowspan="1">MeanTTD</td><td colspan="1" rowspan="1">RangeTTD</td></tr><tr><td colspan="1" rowspan="1">Abiotrophiadefectiva</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">15.9</td><td colspan="1" rowspan="1">14.5-18.0</td><td colspan="1" rowspan="1">100.0(8/8)</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">27.1</td><td colspan="1" rowspan="1">20.4-49.2</td></tr><tr><td colspan="1" rowspan="1">Aggregatibacteractinomycetemcomitans</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">43.1</td><td colspan="1" rowspan="1">35.0-50.5</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">47.5</td><td colspan="1" rowspan="1">42.2-52.1</td></tr><tr><td colspan="1" rowspan="1">Aspergillusbrasiliensis</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">46.2</td><td colspan="1" rowspan="1">39.4-55.4</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">56.9</td><td colspan="1" rowspan="1">48.0-80.4</td></tr><tr><td colspan="1" rowspan="1">Aspergillusfumigatus</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">30.9</td><td colspan="1" rowspan="1">28.6-34.8</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">33.7</td><td colspan="1" rowspan="1">29.5-37.2</td></tr><tr><td colspan="1" rowspan="1">Candida albicans</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">25.4</td><td colspan="1" rowspan="1">23.3-27.9</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">25.5</td><td colspan="1" rowspan="1">24.2-27.1</td></tr><tr><td colspan="1" rowspan="1">Candida glabrata</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">49.0</td><td colspan="1" rowspan="1">41.3-62.8</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">57.3</td><td colspan="1" rowspan="1">52.8-63.8</td></tr><tr><td colspan="1" rowspan="2">Organism</td><td colspan="2" rowspan="1">SA BacT/ALERT VIRTUO With Blood</td><td colspan="1" rowspan="1">UO With</td><td colspan="1" rowspan="1">Blood</td><td colspan="4" rowspan="1">SA BacT/ALERT 3D With Blood</td></tr><tr><td colspan="1" rowspan="1">%Recovery*(n)</td><td colspan="1" rowspan="1">Average CFV/Botle</td><td colspan="1" rowspan="1">MeanTTD</td><td colspan="1" rowspan="1">RangeT TDD</td><td colspan="1" rowspan="1">%Recovery*(n)</td><td colspan="1" rowspan="1">Average FV/botle</td><td colspan="1" rowspan="1">MeanTD</td><td colspan="1" rowspan="1">RangeT D</td></tr><tr><td colspan="1" rowspan="1">Candida krusei</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20.3</td><td colspan="1" rowspan="1">19.6-21.2</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">22.7</td><td colspan="1" rowspan="1">21.8-23.5</td></tr><tr><td colspan="1" rowspan="1">Cardiobacteriumhominis</td><td colspan="1" rowspan="1">1000.0(18/18)</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">46.5</td><td colspan="1" rowspan="1">21.6-51.0</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">52.2</td><td colspan="1" rowspan="1">49.9-57.8</td></tr><tr><td colspan="1" rowspan="1">Corynebacteriumjeikeium</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">30.9</td><td colspan="1" rowspan="1">29.3-33.9</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">33.5</td><td colspan="1" rowspan="1">31.9-36.0</td></tr><tr><td colspan="1" rowspan="1">Cryptococcusneoformans</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">58.8</td><td colspan="1" rowspan="1">48.9-70.1</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">58.8</td><td colspan="1" rowspan="1">52.3-69.8</td></tr><tr><td colspan="1" rowspan="1">Eikenellacorrodens</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">22.9</td><td colspan="1" rowspan="1">21.7-23.8</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">27.0</td><td colspan="1" rowspan="1">26.2-28.3</td></tr><tr><td colspan="1" rowspan="1">Enterobacteraerogenes</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10.9</td><td colspan="1" rowspan="1">9.9-11.9</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">13.3</td><td colspan="1" rowspan="1">12.5-14.4</td></tr><tr><td colspan="1" rowspan="1">Enterococcusfaecalis</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">10.1</td><td colspan="1" rowspan="1">9.2-10.6</td><td colspan="1" rowspan="1">100.0(17/17)</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">12.8</td><td colspan="1" rowspan="1">12.2-13.4</td></tr><tr><td colspan="1" rowspan="1">Escherichia coli</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">9.3</td><td colspan="1" rowspan="1">8.9-9.6</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">11.6</td><td colspan="1" rowspan="1">9.6-12.2</td></tr><tr><td colspan="1" rowspan="1">Fusarium solanicomplex</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">49</td><td colspan="1" rowspan="1">93.0</td><td colspan="1" rowspan="1">64.6-156.7</td><td colspan="1" rowspan="1">94.4(17/18)**</td><td colspan="1" rowspan="1">49</td><td colspan="1" rowspan="1">88.4</td><td colspan="1" rowspan="1">74.4-111.1</td></tr><tr><td colspan="1" rowspan="1">Haemphilusinfluenzae</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">19.7</td><td colspan="1" rowspan="1">17.8-23.8</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">22.4</td><td colspan="1" rowspan="1">20.6-23.8</td></tr><tr><td colspan="1" rowspan="1">Klebsiellapneumoniae</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">9.8</td><td colspan="1" rowspan="1">9.3-10.2</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">12.2</td><td colspan="1" rowspan="1">11.8-12.7</td></tr><tr><td colspan="1" rowspan="1">Listeriamonocytogenes</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">21.2</td><td colspan="1" rowspan="1">19.1-23.3</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">22.4</td><td colspan="1" rowspan="1">20.9-23.8</td></tr><tr><td colspan="1" rowspan="1">Micrococcusluteus</td><td colspan="1" rowspan="1">1000.0(17/17)</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">31.7</td><td colspan="1" rowspan="1">30.6-32.7</td><td colspan="1" rowspan="1">1000.0(18/18)</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">34.4</td><td colspan="1" rowspan="1">33.1-36.0</td></tr><tr><td colspan="1" rowspan="1">Mucorcircinelloides</td><td colspan="1" rowspan="1">94.4(17/18)</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">31.9</td><td colspan="1" rowspan="1">27.1-50.4</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">38.6</td><td colspan="1" rowspan="1">35.0-41.8</td></tr><tr><td colspan="1" rowspan="1">Neisseriameningitidis</td><td colspan="1" rowspan="1">100.0(34/34)</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">18.7</td><td colspan="1" rowspan="1">16.1-21.4</td><td colspan="1" rowspan="1">100.0(35/35)</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">22.2</td><td colspan="1" rowspan="1">20.6-24.7</td></tr><tr><td colspan="1" rowspan="1">Proteus vulgaris</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">11.6</td><td colspan="1" rowspan="1">10.7-12.0</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">14.3</td><td colspan="1" rowspan="1">13.9-14.6</td></tr><tr><td colspan="1" rowspan="1">Pseudomonasaeruginosa</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">13.7</td><td colspan="1" rowspan="1">9.2-14.9</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">17.7</td><td colspan="1" rowspan="1">17.3-18.2</td></tr><tr><td colspan="1" rowspan="1">Salmonellaenterica</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">11.2</td><td colspan="1" rowspan="1">10.4-12.0</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">13.7</td><td colspan="1" rowspan="1">13.0-14.9</td></tr><tr><td colspan="1" rowspan="1">Scedosporiumapiospermum</td><td colspan="1" rowspan="1">100.(18/18)</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">53.4</td><td colspan="1" rowspan="1">49.2-58.3</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">57.7</td><td colspan="1" rowspan="1">52.6-64.6</td></tr><tr><td colspan="1" rowspan="1">Serratiamarcescens</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">11.6</td><td colspan="1" rowspan="1">10.8-13.0</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">18.6</td><td colspan="1" rowspan="1">10.6-98.2</td></tr><tr><td colspan="1" rowspan="1">Staphylococcusaureus</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">11.4</td><td colspan="1" rowspan="1">10.8-12.0</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">15.1</td><td colspan="1" rowspan="1">14.4-16.3</td></tr><tr><td colspan="1" rowspan="1">Staphylococcusepidermidis</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">17.0</td><td colspan="1" rowspan="1">15.9-18.1</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">19.8</td><td colspan="1" rowspan="1">19.0-21.6</td></tr><tr><td colspan="1" rowspan="1">Stenotrophomonasmatophilia</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">23.9</td><td colspan="1" rowspan="1">20.6-27.4</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">22.7</td><td colspan="1" rowspan="1">19.2-23.8</td></tr><tr><td colspan="1" rowspan="1">Streptococcusagalactiae</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">12.0</td><td colspan="1" rowspan="1">10.9-12.8</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">15.7</td><td colspan="1" rowspan="1">14.6-16.6</td></tr><tr><td colspan="1" rowspan="1">Streptococusmitis</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">17</td><td colspan="1" rowspan="1">11.3</td><td colspan="1" rowspan="1">10.3-12.3</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">17</td><td colspan="1" rowspan="1">14.3</td><td colspan="1" rowspan="1">13.7-14.9</td></tr><tr><td colspan="1" rowspan="2">Organism</td><td colspan="4" rowspan="1">SA BacT/ALERT VIRTUO With Blood</td><td colspan="4" rowspan="1">SA BacT/ALERT 3D With Blood</td></tr><tr><td colspan="1" rowspan="1">%Recovery*(n)</td><td colspan="1" rowspan="1">AverageCFU/Bottle</td><td colspan="1" rowspan="1">MeanTTD</td><td colspan="1" rowspan="1">RangeTTD</td><td colspan="1" rowspan="1">%Recovery*(n)</td><td colspan="1" rowspan="1">AverageCFU/bottle</td><td colspan="1" rowspan="1">MeanTTD</td><td colspan="1" rowspan="1">RangeTTD</td></tr><tr><td colspan="1" rowspan="1">Streptococcuspneumoniae</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">11.8</td><td colspan="1" rowspan="1">11.1-12.3</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">15.0</td><td colspan="1" rowspan="1">14.4-15.6</td></tr><tr><td colspan="1" rowspan="1">Streptococcuspyogenes</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">10.5</td><td colspan="1" rowspan="1">9.8-11.6</td><td colspan="1" rowspan="1">100.0(18/18)</td><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">13.3</td><td colspan="1" rowspan="1">13.0-13.7</td></tr></table>

\* Percent Recovery $=$ #detected/#tested \*\*Subculture of negative bottle resulted in no growth.

Table 16. SA Bottles: Growth Performance on BacT/ALERT VIRTUO and on BacT/ALERT 3D in Bottles Tested with No Blood   

<table><tr><td colspan="1" rowspan="2">Organism</td><td colspan="4" rowspan="1">SA BacT/ALERT VIRTUO No Blood</td><td colspan="4" rowspan="1">SA BacT/ALERT 3D No Blood</td></tr><tr><td colspan="1" rowspan="1">%Recovery*(n)</td><td colspan="1" rowspan="1">AverageCFU/Bottle</td><td colspan="1" rowspan="1">MeanTTD</td><td colspan="1" rowspan="1">RangeTTD</td><td colspan="1" rowspan="1">%Recovery*(n)</td><td colspan="1" rowspan="1">AverageCFU/bottle</td><td colspan="1" rowspan="1">MeanTTD</td><td colspan="1" rowspan="1">RangeTTD</td></tr><tr><td colspan="1" rowspan="1">Aggregatibacteractinomycetemcomitans</td><td colspan="1" rowspan="1">100.0(7/7)</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">94.4</td><td colspan="1" rowspan="1">78.0-110.8</td><td colspan="1" rowspan="1">100.0(8/8)</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">82.3</td><td colspan="1" rowspan="1">67.9-106.1</td></tr><tr><td colspan="1" rowspan="1">Aspergillusbrasiliensis</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">46.0</td><td colspan="1" rowspan="1">41.2-50.1</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">52.1</td><td colspan="1" rowspan="1">46.6-58.3</td></tr><tr><td colspan="1" rowspan="1">Aspergillusfumigatus</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">28.2</td><td colspan="1" rowspan="1">24.9-30.0</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">31.3</td><td colspan="1" rowspan="1">29.8-32.6</td></tr><tr><td colspan="1" rowspan="1">Candida albicans</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">25.6</td><td colspan="1" rowspan="1">24.5-27.9</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">26.8</td><td colspan="1" rowspan="1">25.9-27.6</td></tr><tr><td colspan="1" rowspan="1">Candida glabrata</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">24.3</td><td colspan="1" rowspan="1">22.4-25.0</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">26.4</td><td colspan="1" rowspan="1">25.4-27.4</td></tr><tr><td colspan="1" rowspan="1">Candida krusei</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">23.3</td><td colspan="1" rowspan="1">21.9-24.3</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">25.1</td><td colspan="1" rowspan="1">24.2-25.4</td></tr><tr><td colspan="1" rowspan="1">Cryptococcusneoformans</td><td colspan="1" rowspan="1">100.0(8/8)</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">87.7</td><td colspan="1" rowspan="1">79.1-108.2</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">83.6</td><td colspan="1" rowspan="1">79.2-87.6</td></tr><tr><td colspan="1" rowspan="1">Enterobacteraerogenes</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">9.8</td><td colspan="1" rowspan="1">9.3-10.3</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">12.4</td><td colspan="1" rowspan="1">12.2-12.7</td></tr><tr><td colspan="1" rowspan="1">Enterococcusfaecalis</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">10.2</td><td colspan="1" rowspan="1">9.5-10.8</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">13.4</td><td colspan="1" rowspan="1">13.0-13.7</td></tr><tr><td colspan="1" rowspan="1">Escherichia coli</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">9.3</td><td colspan="1" rowspan="1">8.8-9.6</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">12.6</td><td colspan="1" rowspan="1">12.2-13.2</td></tr><tr><td colspan="1" rowspan="1">Fusarium solanicomplex</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">49</td><td colspan="1" rowspan="1">79.8</td><td colspan="1" rowspan="1">63.8-117.8</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">49</td><td colspan="1" rowspan="1">77.9</td><td colspan="1" rowspan="1">72.7-86.2</td></tr><tr><td colspan="1" rowspan="1">Klebsiellapneumoniae</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">9.9</td><td colspan="1" rowspan="1">9.6-10.2</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">12.6</td><td colspan="1" rowspan="1">12.5-13.0</td></tr><tr><td colspan="1" rowspan="1">Listeriamonocytogenes</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20.7</td><td colspan="1" rowspan="1">20.0-21.1</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">23.3</td><td colspan="1" rowspan="1">22.8-23.8</td></tr><tr><td colspan="1" rowspan="1">Micrococcusluteus</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">34.3</td><td colspan="1" rowspan="1">33.6-35.9</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">37.1</td><td colspan="1" rowspan="1">36.2-38.2</td></tr><tr><td colspan="1" rowspan="1">Mucorcircinelloides</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">44.9</td><td colspan="1" rowspan="1">35.6-58.3</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">54.0</td><td colspan="1" rowspan="1">47.0-63.4</td></tr><tr><td colspan="1" rowspan="1">Proteus vulgaris</td><td colspan="1" rowspan="1">100.0</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">11.0</td><td colspan="1" rowspan="1">10.5-</td><td colspan="1" rowspan="1">100.0</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">13.9</td><td colspan="1" rowspan="1">13.7-</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">(9/9)</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">11.7</td><td colspan="1" rowspan="1">(9/9)</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">14.2</td></tr><tr><td colspan="1" rowspan="1">Pseudomonasaeruginosa</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">14.5</td><td colspan="1" rowspan="1">13.6-15.0</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">18.3</td><td colspan="1" rowspan="1">17.8-19.0</td></tr><tr><td colspan="1" rowspan="1">Salmonellaenterica</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">10.6</td><td colspan="1" rowspan="1">10.3-11.0</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">13.5</td><td colspan="1" rowspan="1">13.0-14.2</td></tr><tr><td colspan="1" rowspan="1">Scedosporiumapiospermum</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">51.8</td><td colspan="1" rowspan="1">48.5-56.2</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">58.0</td><td colspan="1" rowspan="1">53.8-60.5</td></tr><tr><td colspan="1" rowspan="1">Serratiamarcescens</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10.6</td><td colspan="1" rowspan="1">10.1-11.0</td><td colspan="1" rowspan="1">100.0(9/9</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">13.5</td><td colspan="1" rowspan="1">13.2-13.9</td></tr><tr><td colspan="1" rowspan="1">Staphylococcusaureus</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">12.1</td><td colspan="1" rowspan="1">11.3-12.8</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">15.8</td><td colspan="1" rowspan="1">14.9-17.0</td></tr><tr><td colspan="1" rowspan="1">Staphylococcusepidermidis</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">18.8</td><td colspan="1" rowspan="1">18.1-19.8</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">23.2</td><td colspan="1" rowspan="1">22.1-26.9</td></tr><tr><td colspan="1" rowspan="1">Stenotrophomonasmaltophilia</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">22.7</td><td colspan="1" rowspan="1">21.5-24.4</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">24.3</td><td colspan="1" rowspan="1">23.3-25.0</td></tr><tr><td colspan="1" rowspan="1">Streptococcusagalactiae</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">11.4</td><td colspan="1" rowspan="1">10.9-12.0</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">15.5</td><td colspan="1" rowspan="1">15.1-15.8</td></tr><tr><td colspan="1" rowspan="1">Streptococcusmitis</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">17</td><td colspan="1" rowspan="1">10.8</td><td colspan="1" rowspan="1">10.0-12.5</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">17</td><td colspan="1" rowspan="1">14.8</td><td colspan="1" rowspan="1">14.6-15.1</td></tr><tr><td colspan="1" rowspan="1">Streptococcuspneumoniae</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">14.3</td><td colspan="1" rowspan="1">13.4-15.4</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">16.7</td><td colspan="1" rowspan="1">16.1-17.3</td></tr><tr><td colspan="1" rowspan="1">Streptococcuspyogenes</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">14.2</td><td colspan="1" rowspan="1">12.5-15.4</td><td colspan="1" rowspan="1">100.0(9/9)</td><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">17.4</td><td colspan="1" rowspan="1">16.6-18.7</td></tr></table>

\*Percent Recovery $=$ #detected/#tested NOTE: Recovery of A. defectiva, $E .$ . corrodens, $H .$ influenzae, $N .$ meningitidis and C. hominis in SA bottles, tested on either instrument, necessitate blood; therefore, SA bottles not containing blood were excluded from analysis for these organisms. For these organisms, refer to Table 15 above for results from bottles containing blood.

Table 17. SN Bottles: Growth Performance on BacT/ALERT VIRTUO and on BacT/ALERT 3D in Bottles Tested with Blood   

<table><tr><td rowspan=2 colspan=1>Organism</td><td rowspan=1 colspan=4>SN BacT/ALERT VIRTUO With Blood</td><td rowspan=1 colspan=4>SN BacT/ALERT 3D With Blood</td></tr><tr><td rowspan=1 colspan=1>%Recovery*(n)</td><td rowspan=1 colspan=1>AverageCFU/Bottle</td><td rowspan=1 colspan=1>MeanTTD</td><td rowspan=1 colspan=1>RangeTTD</td><td rowspan=1 colspan=1>%Recovery*(n)</td><td rowspan=1 colspan=1>AverageCFU/bottle</td><td rowspan=1 colspan=1>MeanTTD</td><td rowspan=1 colspan=1>RangeTTD</td></tr><tr><td rowspan=1 colspan=1>Bacteroidesfragilis</td><td rowspan=1 colspan=1>100.0(11/11)</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>38.5</td><td rowspan=1 colspan=1>27.6-54.3</td><td rowspan=1 colspan=1>100.0(14/14)</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>33.7</td><td rowspan=1 colspan=1>20.6-54.7</td></tr><tr><td rowspan=1 colspan=1>Bacteroidesthetaiotaomicron</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>40.8</td><td rowspan=1 colspan=1>36.2-46.7</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>47.1</td><td rowspan=1 colspan=1>40.6-53.5</td></tr><tr><td rowspan=1 colspan=1>Bacteroidesvulgatus</td><td rowspan=1 colspan=1>100.0(11/11)</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>63.3</td><td rowspan=1 colspan=1>46.9-78.8</td><td rowspan=1 colspan=1>100.0(15/15)</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>62.3</td><td rowspan=1 colspan=1>43.4-85.7</td></tr><tr><td rowspan=1 colspan=1>Clostridiumperfringens</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>27</td><td rowspan=1 colspan=1>8.7</td><td rowspan=1 colspan=1>8.3-9.2</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>27</td><td rowspan=1 colspan=1>11.6</td><td rowspan=1 colspan=1>11.0-12.2</td></tr><tr><td rowspan=1 colspan=1>Clostridiumsepticum</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>9.8</td><td rowspan=1 colspan=1>9.0-10.7</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>12.9</td><td rowspan=1 colspan=1>12.0-13.4</td></tr><tr><td rowspan=1 colspan=1>Eggerthella lenta</td><td rowspan=1 colspan=1>88.2**(15/17)</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>43.6</td><td rowspan=1 colspan=1>26.5-91.0</td><td rowspan=1 colspan=1>94.4**(17/18)</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>40.8</td><td rowspan=1 colspan=1>19.7-57.4</td></tr><tr><td rowspan=1 colspan=1>Enterococcusfaecalis</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>9.9</td><td rowspan=1 colspan=1>9.3-10.6</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>12.6</td><td rowspan=1 colspan=1>12.2-13.7</td></tr><tr><td rowspan=1 colspan=1>Escherichia coli</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>8.6</td><td rowspan=1 colspan=1>8.0-9.1</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>10.9</td><td rowspan=1 colspan=1>9.8-11.5</td></tr><tr><td rowspan=1 colspan=1>Fusobacteriumnucleatum</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>32.8</td><td rowspan=1 colspan=1>13.8-50.0</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>39.7</td><td rowspan=1 colspan=1>21.4-53.8</td></tr><tr><td rowspan=1 colspan=1>Parvimonas micra</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>24</td><td rowspan=1 colspan=1>45.2</td><td rowspan=1 colspan=1>28.0-64.2</td><td rowspan=1 colspan=1>100.0(17/17)</td><td rowspan=1 colspan=1>24</td><td rowspan=1 colspan=1>49.4</td><td rowspan=1 colspan=1>21.6-74.6</td></tr><tr><td rowspan=1 colspan=1>Peptoniphilusasaccharolyticus</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>33.1</td><td rowspan=1 colspan=1>27.8-39.3</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>42.5</td><td rowspan=1 colspan=1>36.2-58.3</td></tr><tr><td rowspan=1 colspan=1>Staphylococcusaureus</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>10.3</td><td rowspan=1 colspan=1>9.9-11.1</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>13.3</td><td rowspan=1 colspan=1>12.7-13.9</td></tr><tr><td rowspan=1 colspan=1>Streptococcuspneumoniae</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>11.9</td><td rowspan=1 colspan=1>11.3-12.6</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>15.1</td><td rowspan=1 colspan=1>14.4-15.8</td></tr><tr><td rowspan=1 colspan=1>Streptococcuspyogenes</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>9.7</td><td rowspan=1 colspan=1>9.1-10.3</td><td rowspan=1 colspan=1>100.0(18/18)</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>12.2</td><td rowspan=1 colspan=1>11.3-12.7</td></tr></table>

\* Percent Recovery $=$ #detected/#tested \*\*Three SN bottles spiked with Eggerthella lenta were called negative by VIRTUO (2 bottles) and BTA 3D (1 bottle). Growth was observed upon subculture of all bottles; therefore these three bottles were considered false negatives.

Table 18. SN Bottles: Growth Performance on BacT/ALERT VIRTUO and on BacT/ALERT 3D in Bottles Tested with No Blood   

<table><tr><td rowspan=2 colspan=1>Organism</td><td rowspan=1 colspan=4>SN BacT/ALERT VIRTUO No Blood</td><td rowspan=1 colspan=4>SN BacT/ALERT 3D No Blood</td></tr><tr><td rowspan=1 colspan=1>%Recovery*(n)</td><td rowspan=1 colspan=1>AverageCFU/Bottle</td><td rowspan=1 colspan=1>MeanTTD</td><td rowspan=1 colspan=1>RangeTTD</td><td rowspan=1 colspan=1>%Recovery*(n)</td><td rowspan=1 colspan=1>AverageCFU/bottle</td><td rowspan=1 colspan=1>MeanTTD</td><td rowspan=1 colspan=1>RangeTTD</td></tr><tr><td rowspan=1 colspan=1>Bacteroidesfragilis</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>25.0</td><td rowspan=1 colspan=1>23.3-28.5</td><td rowspan=1 colspan=1>100.0(8/8)</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>29.5</td><td rowspan=1 colspan=1>28.8-30.0</td></tr><tr><td rowspan=1 colspan=1>Bacteroidesthetaiotaomicron</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>25.5</td><td rowspan=1 colspan=1>23.7-27.3</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>29.5</td><td rowspan=1 colspan=1>28.3-31.7</td></tr><tr><td rowspan=1 colspan=1>Bacteroidesvulgatus</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>27.2</td><td rowspan=1 colspan=1>25.6-28.3</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>31.4</td><td rowspan=1 colspan=1>31.0-32.4</td></tr><tr><td rowspan=1 colspan=1>Clostridiumperfringens</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>27</td><td rowspan=1 colspan=1>8.0</td><td rowspan=1 colspan=1>7.7-8.5</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>27</td><td rowspan=1 colspan=1>10.9</td><td rowspan=1 colspan=1>10.6-11.3</td></tr><tr><td rowspan=1 colspan=1>Clostridiumsepticum</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>12.0</td><td rowspan=1 colspan=1>10.4-15.1</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>16.5</td><td rowspan=1 colspan=1>15.1-18.2</td></tr><tr><td rowspan=1 colspan=1>Eggerthella lenta</td><td rowspan=1 colspan=1>100.0(8/8)</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>24.5</td><td rowspan=1 colspan=1>23.2-25.7</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>27.5</td><td rowspan=1 colspan=1>27.1-28.3</td></tr><tr><td rowspan=1 colspan=1>Enterococcusfaecalis</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>9.4</td><td rowspan=1 colspan=1>8.9-10.2</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>12.6</td><td rowspan=1 colspan=1>12.2-13.0</td></tr><tr><td rowspan=1 colspan=1>Escherichia coli</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>8.3</td><td rowspan=1 colspan=1>7.9-9.0</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>11.0</td><td rowspan=1 colspan=1>10.6-11.8</td></tr><tr><td rowspan=1 colspan=1>Fusobacteriumnucleatum</td><td rowspan=1 colspan=1>100.0(8/8)</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>28.3</td><td rowspan=1 colspan=1>24.9-31.5</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>42.0</td><td rowspan=1 colspan=1>34.8-49.2</td></tr><tr><td rowspan=1 colspan=1>Parvimonas micra</td><td rowspan=1 colspan=1>100.0(8/8)</td><td rowspan=1 colspan=1>24</td><td rowspan=1 colspan=1>38.0</td><td rowspan=1 colspan=1>36.3-40.2</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>24</td><td rowspan=1 colspan=1>43.8</td><td rowspan=1 colspan=1>42.0-45.1</td></tr><tr><td rowspan=1 colspan=1>Peptoniphilusasaccharolyticus</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>29.2</td><td rowspan=1 colspan=1>28.1-31.5</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>37.1</td><td rowspan=1 colspan=1>35.5-38.9</td></tr><tr><td rowspan=1 colspan=1>Staphylococcusaureus</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>11.4</td><td rowspan=1 colspan=1>11.0-12.0</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15.2</td><td rowspan=1 colspan=1>14.9-15.6</td></tr><tr><td rowspan=1 colspan=1>Streptococcuspneumoniae</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>14.3</td><td rowspan=1 colspan=1>13.3-15.4</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>17.2</td><td rowspan=1 colspan=1>16.3-17.8</td></tr><tr><td rowspan=1 colspan=1>Streptococcuspyogenes</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>10.4</td><td rowspan=1 colspan=1>9.5-11.7</td><td rowspan=1 colspan=1>100.0(9/9)</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>13.5</td><td rowspan=1 colspan=1>13.0-14.4</td></tr></table>

\*Percent Recovery $=$ #detected/#tested

In summary, results of the Growth Performance study demonstrated equivalent performance for VIRTUO and BTA 3D systems for detection and recovery of representative organisms in FA Plus, FN Plus, SA and SN bottles. The study demonstrated $100 \%$ detection for the majority of organisms evaluated in each bottle type. The following differences in detection were observed between instruments:

FA Plus bottles, Cardiobacterium hominis (without blood): 0/9 detected on BTA 3D, 9/9 detected on VIRTUO   
FN Plus bottles, Eggerthella lenta (with blood): 16/18 bottles detected on BTA 3D, 18/18 detected on VIRTUO   
FN Plus bottles, Fusobacterium nucleatum (with blood): 6/13 bottles detected on BTA 3D, 18/18 detected on VIRTUO.   
SA bottles, Fusarium solani complex (with blood): 17/18 bottles detected on BTA 3D, 18/18 detected on VIRTUO.

SN bottles, Eggerthella lenta (without blood): 17/18 bottles detected on BTA 3D, 15/17 bottles detected on VIRTUO.

# e. Evaluation of Delay in Bottle Entry

As stated in the labeling for FA Plus, FN Plus, PF Plus, SA and SN bottles, it is recommended that bottles are loaded onto the instrument as soon as possible. If a delay is inevitable, it is recommend that bottles should be held at room temperature for no longer than 24 hours. The following statement is also included in each bottle package insert:

# \* CAUTION: Culture bottles held at room temperature for longer than 24 hours before loading may not detect microorganisms and should be subcultured.

An analytical study was performed to evaluate potential effects on bottle/instrument performance for bottles that are delayed between specimen collection and loading onto the VIRTUO system. The following delay conditions were evaluated:

· $2 { - } 8 ^ { \circ } \mathrm { C }$ for 48 hours · $2 0 { - } 2 5 ^ { \circ } \mathrm { C }$ for 24 hours · $2 0 { - } 2 5 ^ { \circ } \mathrm { C }$ for 36 hours · $3 5 . 3 7 ^ { \circ } \mathrm { C }$ for 8 hours

Testing was conducted using bottles containing 0, 4 and/or $1 0 ~ \mathrm { m L }$ pooled fresh human blood at target organism concentrations of $\leq 1 0 0$ CFU/bottle. The study included three lots for each bottle type and a minimum of nine bottles for each combination of bottle type, organism, hold time, temperature condition and blood volume. Percent recovery reflects bottles flagged positive by the instrument and subculture with colony morphology consistent with the seeded organism.

FA Plus Bottles/Delayed Entry (VIRTUO):

For FA Plus bottles tested on VIRTUO, 9 species were evaluated (Staphylococcus aureus, Candida albicans, Escherichia coli, Acinetobacter baumannii, Pseudomonas aeruginosa, Haemophilus influenzae, Neisseria meningitidis, Streptococcus pneumoniae, and Enterococcus faecium) at target concentrations of $\leq 1 0 0$ CFU/bottle. Actual inoculum levels ranged from 5-84 CFU/bottle. The study demonstrated $5 9 9 \%$ recovery with the exception of culture bottles held at $2 { - } 8 ^ { \circ } \mathrm { C }$ for 48 hours for which 12 of 13 bottles spiked with N. meningitidis were negative. The study results are shown in Table 19 below.

Table 19. FA Plus Bottles: Delayed Entry (VIRTUO)   

<table><tr><td rowspan=2 colspan=1>Sample Input</td><td rowspan=2 colspan=1>IncubationTemperature()</td><td rowspan=2 colspan=1>Hold Time(hours)</td><td rowspan=2 colspan=1>% Recovery(# detected/#tested)</td><td rowspan=1 colspan=2>Time to Detection fromSample Inoculation(Hold Time + Instrument TTD inhours)</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Range</td></tr><tr><td rowspan=5 colspan=1>InoculatedTest Bottles</td><td rowspan=1 colspan=1>Control</td><td rowspan=1 colspan=1>No delay</td><td rowspan=1 colspan=1>100 (539/539)</td><td rowspan=1 colspan=1>14.0</td><td rowspan=1 colspan=1>8.5-40.5</td></tr><tr><td rowspan=1 colspan=1>35-37</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>99.8 (538/539)</td><td rowspan=1 colspan=1>17.0</td><td rowspan=1 colspan=1>10.7-37.4</td></tr><tr><td rowspan=1 colspan=1>20-25</td><td rowspan=1 colspan=1>24</td><td rowspan=1 colspan=1>100 (539/539)</td><td rowspan=1 colspan=1>33.3</td><td rowspan=1 colspan=1>27.4-78.8</td></tr><tr><td rowspan=1 colspan=1>20-25</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>99.8 (535/536)</td><td rowspan=1 colspan=1>43.7</td><td rowspan=1 colspan=1>37.5-130.1</td></tr><tr><td rowspan=1 colspan=1>2-8</td><td rowspan=1 colspan=1>48</td><td rowspan=1 colspan=1>97.6(519/532)*</td><td rowspan=1 colspan=1>62.5</td><td rowspan=1 colspan=1>56.9-87.5</td></tr><tr><td rowspan=1 colspan=1>NegativeControls</td><td rowspan=1 colspan=2>All conditions</td><td rowspan=1 colspan=1>0 (0/64)†</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>-</td></tr></table>

\*12 Negative bottles out of 13 were observed when tested with $N .$ . meningitidis † Negative controls tested with $1 0 ~ \mathrm { m L }$ human blood

# FN Plus/Delayed Entry (VIRTUO):

For FN Plus bottles tested on VIRTUO, 6 species were evaluated (Staphylococcus aureus, Escherichia coli, Streptococcus pneumoniae, Enterococcus faecium, Bacteroides fragilis, and Clostridium perfringens) at target concentrations of $\leq 1 0 0$ CFU/bottle. Actual inoculum levels ranged from 9-84 CFU/bottle. For all organisms and delay conditions evaluated, study results demonstrated $100 \%$ recovery. The study results are shown in Table 20 below.

Table 20. FN Plus Bottles: Delayed Entry (VIRTUO)   

<table><tr><td rowspan=2 colspan=1>Sample Input</td><td rowspan=2 colspan=1>IncubationTemperature(C)</td><td rowspan=2 colspan=1>Hold Time(hours)</td><td rowspan=2 colspan=1>% Recovery(# detected/ #tested)</td><td rowspan=1 colspan=2>Time to Detection from SampleInoculation(Hold Time + Instrument TTD inhours)</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Range</td></tr><tr><td rowspan=5 colspan=1>InoculatedTest Bottles</td><td rowspan=1 colspan=1>Control</td><td rowspan=1 colspan=1>No delay</td><td rowspan=1 colspan=1>100.0 (144/144)</td><td rowspan=1 colspan=1>16.0</td><td rowspan=1 colspan=1>9.1-40.5</td></tr><tr><td rowspan=1 colspan=1>2-8</td><td rowspan=1 colspan=1>48</td><td rowspan=1 colspan=1>100.0 (141/141)</td><td rowspan=1 colspan=1>65.1</td><td rowspan=1 colspan=1>56.9-87.5</td></tr><tr><td rowspan=1 colspan=1>20-25</td><td rowspan=1 colspan=1>24</td><td rowspan=1 colspan=1>100.0 (143/143)</td><td rowspan=1 colspan=1>37.0</td><td rowspan=1 colspan=1>27.5-78.8</td></tr><tr><td rowspan=1 colspan=1>20-25</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>100.0 (141/141)</td><td rowspan=1 colspan=1>48.1</td><td rowspan=1 colspan=1>37.9-130.1</td></tr><tr><td rowspan=1 colspan=1>35-37</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>100.0 (143/143)</td><td rowspan=1 colspan=1>18.9</td><td rowspan=1 colspan=1>10.8-37.4</td></tr><tr><td rowspan=1 colspan=1>NegativeControls</td><td rowspan=1 colspan=2>All conditions</td><td rowspan=1 colspan=1>0.0 (0/30)</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>-</td></tr></table>

# SA Bottles/Delayed Entry (VIRTUO)

For SA bottles tested on VIRTUO, 11 species (Staphylococcus aureus, Candida albicans, Candida krusei, Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Haemophilus influenzae, Neisseria meningitidis, Streptococcus pneumoniae, and Enterococcus faecium) were evaluated at target concentrations of $\leq 1 0 0$ CFU/bottle. Actual inoculum levels ranged from 4-51 CFU/bottle. The study results support the bottle performance for the recommended delay conditions of 24 hours at room temperature with the exception of bottles seeded with N. meningitidis. For this condition, 17/18 bottles spiked with N. meningitidis were unexpectedly negative. It was noted however that 18/18 SA bottles with $N .$ . meningitidis were positive when tested after a 36 hour delay at room temperature. It was thought that the unexpected negative results for the 24 hour/room temperature condition were due to inoculation errors and it was determined that repeat testing would not be necessary. The study results are shown in Table 21 below.

Table 21. SA Bottles: Delayed Entry VIRTUO   

<table><tr><td rowspan=2 colspan=1>Sample Input</td><td rowspan=2 colspan=1>IncubationTemperature(C)</td><td rowspan=2 colspan=1>Hold Time(hours)</td><td rowspan=2 colspan=1>% Recovery(# detected/ #tested)</td><td rowspan=1 colspan=2>Time to Detection from SampleInoculation(Hold Time + Instrument TTD inhours)</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Range</td></tr><tr><td rowspan=5 colspan=1>Inoculated TestBottles</td><td rowspan=1 colspan=1>Control</td><td rowspan=1 colspan=1>No delay</td><td rowspan=1 colspan=1>99.4 (307/309)</td><td rowspan=1 colspan=1>15.7</td><td rowspan=1 colspan=1>9.4 - 36.4</td></tr><tr><td rowspan=1 colspan=1>35-37</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>99.7 (306/307)</td><td rowspan=1 colspan=1>17.5</td><td rowspan=1 colspan=1>11.2  79.3</td></tr><tr><td rowspan=1 colspan=1>20-25</td><td rowspan=1 colspan=1>24</td><td rowspan=1 colspan=1>94.4 (289/306)*</td><td rowspan=1 colspan=1>33.2</td><td rowspan=1 colspan=1>27.1 - 55.4</td></tr><tr><td rowspan=1 colspan=1>20-25</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>99.3 (303/305)</td><td rowspan=1 colspan=1>44.0</td><td rowspan=1 colspan=1>37.5  88.8</td></tr><tr><td rowspan=1 colspan=1>2-8</td><td rowspan=1 colspan=1>48</td><td rowspan=1 colspan=1>87.5(266/304)**</td><td rowspan=1 colspan=1>63.8</td><td rowspan=1 colspan=1>56.3  85.8</td></tr><tr><td rowspan=1 colspan=1>NegativeControls</td><td rowspan=1 colspan=2>All conditions</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1></td></tr></table>

$^ { * } 1 7 / 1 8$ bottles with $N .$ . meningitidis were negative for the 24 hour room temperature delay condition. 18/18 bottles with $N .$ . meningitidis were recovered at 36 hour room temperature delay condition. Therefore, results at 24 hours are likely due to issues with bottle inoculation. $^ { * * } 1 7 / 1 8$ bottles with $N .$ meningitidis were negative for the 48 hour $2 { - } 8 ^ { \circ } \mathrm { C }$ delay condition

SN Bottles/Delayed Entry (VIRTUO): For SN bottles tested on VIRTUO, 6 species were evaluated (Staphylococcus aureus, Escherichia coli, Streptococcus pneumoniae, Enterococcus faecium, Bacteroides fragilis, and Clostridium perfringens) at target concentrations of $\leq 1 0 0$ CFU/bottle. Actual inoculum levels ranged from 9-84 CFU/bottle. For all organisms and delay conditions evaluated, study results demonstrated $100 \%$ recovery. The study results are shown in Table 22 below.

Table 22. SN Bottles, Delayed Entry   

<table><tr><td rowspan=2 colspan=1>Sample Input</td><td rowspan=2 colspan=1>IncubationTemperature()</td><td rowspan=2 colspan=1>Hold Time(hours)</td><td rowspan=2 colspan=1>% Recovery(# detected/#tested)</td><td rowspan=1 colspan=2>Time to Detection from SampleInoculation(Hold Time + Instrument TTD inhours)</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Range</td></tr><tr><td rowspan=5 colspan=1>Inoculated TestBottles</td><td rowspan=1 colspan=1>Control</td><td rowspan=1 colspan=1>No delay</td><td rowspan=1 colspan=1>100.0 (144/144)</td><td rowspan=1 colspan=1>16.0</td><td rowspan=1 colspan=1>9.1-40.5</td></tr><tr><td rowspan=1 colspan=1>2-8</td><td rowspan=1 colspan=1>48</td><td rowspan=1 colspan=1>100.0 (141/141)</td><td rowspan=1 colspan=1>65.1</td><td rowspan=1 colspan=1>56.9-87.5</td></tr><tr><td rowspan=1 colspan=1>20-25</td><td rowspan=1 colspan=1>24</td><td rowspan=1 colspan=1>100.0 (143/143)</td><td rowspan=1 colspan=1>37.0</td><td rowspan=1 colspan=1>27.5-78.8</td></tr><tr><td rowspan=1 colspan=1>20-25</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>100.0 (141/141)</td><td rowspan=1 colspan=1>48.1</td><td rowspan=1 colspan=1>37.9-130.1</td></tr><tr><td rowspan=1 colspan=1>35-37</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>100.0 (143/143)</td><td rowspan=1 colspan=1>18.9</td><td rowspan=1 colspan=1>10.8-37.4</td></tr><tr><td rowspan=1 colspan=1>Negative Controls</td><td rowspan=1 colspan=2>All conditions</td><td rowspan=1 colspan=1>0.0 (0/30)</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>-</td></tr></table>

# f. Interfering Substances

An in-house study was conducted to evaluate FA Plus and FN Plus bottles on VIRTUO for the effect of potentially interfering substance. Seeded studies were conducted with CSF, pleural fluid, synovial fluid, plasma, and blood. Potential interferents included WBC at ${ \sim } 1 \mathrm { ~ x ~ } \mathrm { i } \mathrm { 0 } ^ { 7 } / \mathrm { m L }$ as well as blood clots. Testing included bottles without organism as well as bottles seeded with organism concentrations between 65 and 120 CFU/bottle. A total of five bottles were evaluated for each bottle type, microorganism, specimen type, and interfering substance combination shown in Table 23 below.

Table 23: Interference Testing   

<table><tr><td colspan="1" rowspan="1">Sterile BodyFluid</td><td colspan="1" rowspan="1">Category perCLSI H56-A</td><td colspan="1" rowspan="1">Test Organism(s)</td><td colspan="1" rowspan="1">Supplements</td><td colspan="1" rowspan="1">BottlesTested</td></tr><tr><td colspan="1" rowspan="1">Peritoneal Fluid</td><td colspan="1" rowspan="1">Serous</td><td colspan="1" rowspan="1">Staphylococcus aureusandStreptococcus pneumoniae</td><td colspan="1" rowspan="1">WBC andClots</td><td colspan="1" rowspan="1">FA PlusandFN Plus</td></tr><tr><td colspan="1" rowspan="1">Synovial (Joint)Fluid</td><td colspan="1" rowspan="1">Synovial</td><td colspan="1" rowspan="1">Staphylococcus aureus</td><td colspan="1" rowspan="1">WBC andClots</td><td colspan="1" rowspan="1">FA PlusandFN Plus</td></tr><tr><td colspan="1" rowspan="1">CerebrospinalFluid</td><td colspan="1" rowspan="1">Cerebral spinalfluid and Ventricularshunt Fluids</td><td colspan="1" rowspan="1">Neisseria meningitidis*</td><td colspan="1" rowspan="1">WBC andClots</td><td colspan="1" rowspan="1">FA Plus</td></tr><tr><td colspan="1" rowspan="1">Blood</td><td colspan="1" rowspan="1">N/A</td><td colspan="1" rowspan="1">Staphylococcus aureus</td><td colspan="1" rowspan="1">WBC andClots</td><td colspan="1" rowspan="1">FA PlusandFN Plus</td></tr><tr><td colspan="1" rowspan="1">Plasma</td><td colspan="1" rowspan="1">N/A</td><td colspan="1" rowspan="1">Staphylococcus aureus</td><td colspan="1" rowspan="1">None</td><td colspan="1" rowspan="1">FA PlusandFN Plus</td></tr></table>

\*Note: 4 mL blood added

Testing of each bottle type, specimen type, microorganism and potentially interfering substance generated $100 \%$ of the expected positive and negative results. In addition, the time to detection for each specimen type and bottle was not significantly impacted by the presence of WBC or blood clots.

g. Assay cut-off: Not Applicable

2. Comparison studies:

Method comparison with predicate device:

# Section M.2.I: Clinical Study to Evaluate Blood Cultures on VIRTUO and BTA 3D

A multi-center clinical study was conducted to compare the performance of the VIRTUO and BTA 3D Systems with blood cultures collected in FA Plus, FN Plus, PF Plus, SA, and SN culture bottles. The study included evaluation of matched pairs of the same bottle type with one bottle incubated on BTA 3D and the other incubated on VIRTUO. For each bottle type, the performance of VIRTUO was considered substantially equivalent to the BTA 3D if the upper limit of the $9 5 \%$ confidence interval for the ratio of system agreement with positive clinical determination (true positive rate) for the total compliant samples/isolates (significant, contaminated and unknown) contained a value of 1.

The target quantity for adult bottles (FA Plus, FN Plus, SA and SN) was $8 { \cdot } 1 0 \mathrm { m L }$ per bottle and overfilled bottle test pairs (either bottle) of an adult pair with a volume greater than the maximum $1 0 \mathrm { m l }$ blood fill were excluded from the analysis. For purposes of data analysis, the paired bottles for adult blood culture bottles were considered compliant if the blood volume of the bottle with the smallest volume was within $30 \%$ of the blood volume of the bottle with the largest volume.

The target quantity for pediatric bottles (PF Plus) was $4 \mathrm { m L }$ per bottle. PF Plus blood culture bottle pairs were considered compliant if the following criteria were met:

(a) if the total volume of blood collected from a pediatric patient was greater than 5 mL, the blood volume of the bottle with the smallest volume is within $20 \%$ of the blood volume of the bottle with the larger volume or

(b) if the total volume of blood collected from a pediatric patient was equal to or less than $5 \mathrm { m L }$ , the blood volume of the bottle with the smallest volume is within $50 \%$ of the blood volume of the bottle with the largest volume.

Overfilled bottle test pairs (either bottle) of a PF Plus bottle pair with a volume greater than the maximum $4 \mathrm { m l }$ blood fill were excluded from the analysis. All bottles that were flagged as positive by the instrument were subcultured and a minimum of $30 \%$ of all negative blood cultures were subcultured. A culture bottle was determined to be a “True Positive” if flagged positive by the instrument and if an isolate or isolates were recovered by subculture. True positive rates were calculated for each bottle and specimen type on BTA 3D and on VIRTUO, and the ratio of VIRTUO true positives to BTA 3D true positives was calculated to compare performance between instruments. Clinical isolates recovered from each subcultured bottle were classified as significant, contaminant, or unknown. Classification was performed by clinicians at each clinical site and was based on patient chart review in conjunction with predetermined criteria.

A culture bottle was determined to be false negative if the bottle result was negative by the instrument and resulted in growth upon subculture of the bottle.

A culture bottle was determined to be false positive if the instrument signaled the bottle as positive but no viable organisms were present in the bottle as confirmed by Gram stain and subculture.

Results are shown below for blood culture specimens collected in FA Plus, FN Plus, PF Plus, SA and SN bottle pairs of which one bottle was tested on VIRTUO and the other bottle was tested on BTA 3D.

# Section M.2.I.a- FA Plus Bottles (Blood Cultures) Clinical Performance:

A total of 1441 FA Plus bottle pairs obtained from 750 adult patients suspected of blood stream bacterial/yeast infections were tested on both VIRTUO and BTA 3D. Of these, 1053 bottle pairs from 637 patients were determined as compliant.

A total of 98 isolates were recovered from all compliant FA Plus bottle pairs with a positive status. At least one isolate was recovered by subculture from 94 FA Plus bottle pairs incubated on VIRTUO and/or BTA 3D. Two isolates were recovered from two bottle pairs and three isolates were recovered from one bottle pair. A total of 73 isolates were recovered from FA Plus bottles on VIRTUO and a total of 79 isolates were recovered from FA Plus bottles on BTA 3D. Of the significant isolates, a total of 64 isolates were recovered from FA Plus bottles on VIRTUO compared to a total of 66 isolates recovered from FA Plus bottles on BTA 3D.

No false positives FA Plus bottles were observed on VIRTUO (0/1057) or BTA 3D (0/1057).

Terminal subcultures were performed for 624 FA Plus bottle pairs that were negative on both VIRTUO and BTA 3D. False negative results were observed for both bottles of one bottle pair. For negative bottle pairs for which both bottles were subcultured, the final false negative rate was $0 . 1 6 \%$ for both instruments.

The following tables compare results of true positive blood cultures incubated on VIRTUO and BTA 3D for all compliant FA Plus culture bottles yielding any number of isolates on subculture (Table 24), a single isolate on subculture (Table 25), and multiple isolates on subculture (Table 26).

Table 24. FA Plus - Blood – Compliant – Single and Multiple Isolates Combined   

<table><tr><td rowspan=1 colspan=1>ClinicalDetermination</td><td rowspan=1 colspan=1>VIRTUOTruePositives</td><td rowspan=1 colspan=1>% of VIRTUOTrue Positives inPopulation</td><td rowspan=1 colspan=1>BTA3DTruePositives</td><td rowspan=1 colspan=1>% of BTA3DTrue Positives inPopulation</td><td rowspan=1 colspan=1>Ratio ofTruePositives(VIRTUO/BTA3D)</td><td rowspan=1 colspan=1>95% CI(LCL,UCL</td></tr><tr><td rowspan=1 colspan=1>Significant</td><td rowspan=1 colspan=1>64</td><td rowspan=1 colspan=1>6.1 (64/1057)</td><td rowspan=1 colspan=1>66</td><td rowspan=1 colspan=1>6.2 (66/1057)</td><td rowspan=1 colspan=1>0.970</td><td rowspan=1 colspan=1>0.821,1.119</td></tr><tr><td rowspan=1 colspan=1>Contaminant</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>0.7 (7/1057)</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>1.0 (11/1057)</td><td rowspan=1 colspan=1>0.636</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Unknown</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0.2 (2/1057)</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0.2 (2/1057)</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>73</td><td rowspan=1 colspan=1>6.9 (73/1057)</td><td rowspan=1 colspan=1>79</td><td rowspan=1 colspan=1>7.5 (79/1057)</td><td rowspan=1 colspan=1>0.924</td><td rowspan=1 colspan=1>0.766,1.082</td></tr></table>

\* Confidence intervals not calculated due to small sample size.

Table 25. FA Plus - Blood – Single Isolates   

<table><tr><td rowspan=1 colspan=1>ClinicalDetermination</td><td rowspan=1 colspan=1>VIRTUOTruePositives</td><td rowspan=1 colspan=1>% of VIRTUOTrue Positives inPopulation</td><td rowspan=1 colspan=1>BTA3DTruePositives</td><td rowspan=1 colspan=1>% of BTA3DTrue Positives inPopulation</td><td rowspan=1 colspan=1>Ratio ofTruePositives(VIRTUO/BTA3D)</td><td rowspan=1 colspan=1>95% CI(LCL,UCL</td></tr><tr><td rowspan=1 colspan=1>Significant</td><td rowspan=1 colspan=1>57</td><td rowspan=1 colspan=1>5.4 (57/1050)</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>5.7 (60/1050)</td><td rowspan=1 colspan=1>0.950</td><td rowspan=1 colspan=1>0.791,1.109</td></tr><tr><td rowspan=1 colspan=1>Contaminant</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>0.7 (7/1050)</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>1.0 (11/1050)</td><td rowspan=1 colspan=1>0.636</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Unknown</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0.2 (2/1050)</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0.2 (2/1050)</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>66</td><td rowspan=1 colspan=1>6.3 (66/1050)</td><td rowspan=1 colspan=1>73</td><td rowspan=1 colspan=1>7.0 (73/1050)</td><td rowspan=1 colspan=1>0.904</td><td rowspan=1 colspan=1>0.737,1.071</td></tr></table>

\* Confidence intervals not calculated due to small sample size.

Table 26. FA Plus - Blood – Multiple Isolates   

<table><tr><td rowspan=1 colspan=1>ClinicalDetermination</td><td rowspan=1 colspan=1>VIRTUOTruePositives</td><td rowspan=1 colspan=1>% of VIRTUOTrue Positives inPopulation</td><td rowspan=1 colspan=1>BTA3DTruePositives</td><td rowspan=1 colspan=1>% of BTA3DTrue Positives inPopulation</td><td rowspan=1 colspan=1>Ratio ofTruePositives(VIRTUO/BTA3D)</td><td rowspan=1 colspan=1>95% CI(LCL,UCL</td></tr><tr><td rowspan=1 colspan=1>Significant</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>100.0 (7/7)</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>85.7 (6/7)</td><td rowspan=1 colspan=1>1.167</td><td rowspan=1 colspan=1>0.814,1.520</td></tr><tr><td rowspan=1 colspan=1>Contaminant</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0 (0/7)</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0 (0/7)</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Unknown</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0 (0/7)</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0 (0/7)</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>100.0 (7/7)</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>85.7 (6/7)</td><td rowspan=1 colspan=1>1.167</td><td rowspan=1 colspan=1>0.814,1.520</td></tr></table>

\* Confidence intervals not calculated due to small sample size.

Table 27 includes the comparative yield of microorganisms (number of isolates) recovered on subculture from FA Plus bottles incubated on VIRTUO and BTA 3D.

Table 27: FA Plus: Comparative Yield of Microorganisms (Number of Isolates) – Blood Cultures   

<table><tr><td rowspan=1 colspan=1>Group</td><td rowspan=1 colspan=1>BacT/ALERTVIRTUO</td><td rowspan=1 colspan=1>BacT/ALERT 3D</td></tr><tr><td rowspan=1 colspan=1>Anaerobes</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Enterobacteriaceae</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Enterococcus spp.</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>7</td></tr><tr><td rowspan=1 colspan=1>Yeasts</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Non-fermentative Gram-Negative Bacilli</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>5</td></tr><tr><td rowspan=1 colspan=1>Other Gram-Negative</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Other Gram-Positive</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>5</td></tr><tr><td rowspan=1 colspan=1>Coagulase-Negative Staphylococcus</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>16</td></tr><tr><td rowspan=1 colspan=1>Staphylococcus aureus</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>19</td></tr><tr><td rowspan=1 colspan=1>Streptococcus spp.</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>6</td></tr><tr><td rowspan=1 colspan=1>Other</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>All</td><td rowspan=1 colspan=1>73</td><td rowspan=1 colspan=1>79</td></tr></table>

Note: Table includes polymicrobic cultures

# Section M.2I.b- FN Plus Bottles (Blood) Clinical Performance:

A total of 1181 FN Plus bottle pairs, obtained from 582 adult patients suspected of blood stream bacterial/yeast infections were tested on both VIRTUO and BTA 3D. Of these, 906 bottle pairs from 513 patients were determined as compliant.

A total of 73 isolates were recovered from all compliant FN Plus Culture Bottle pairs with a positive status. At least one isolate was recovered by subculture from 67 bottle pairs incubated on VIRTUO or BTA 3D respectively. A single isolate was recovered from 62 bottle pairs, two isolates were recovered from four bottle pairs, and three isolates were recovered from one bottle pair.

A total of 60 isolates were recovered from FN Plus bottles on VIRTUO and a total of 58 isolates were recovered from FN Plus bottles on BTA 3D. Of the significant isolates, the

VIRTUO FN Plus bottles detected a total of 47 isolates compared to the BTA 3D FN Plus bottles which detected 48 isolates.

Two false positive FN Plus bottles were observed on VIRTUO (2/912, $0 . 2 2 \%$ and one false positive FN Plus Culture Bottle was observed on BTA 3D (1/912, $0 . 1 1 \%$ .

Terminal subcultures were performed for 593 FN Plus bottle pairs that were negative on both VIRTUO and BTA 3D. A total of six false negative bottles were observed for FN Plus bottles on both VIRTUO and BTA 3D. For negative bottle pairs for which both bottles were subcultured, the final false negative rate was $1 . 0 1 \%$ (6/593) for both instruments.

The following tables compare true positive results of blood cultures incubated on VIRTUO and BTA 3D for all compliant FN Plus blood culture bottles yielding any number of isolates on subculture (Table 28), a single isolate on subculture (Table 29), and multiple isolates on subculture (Table 30).

Table 28. FN Plus – Blood – Compliant – Single and Multiple Isolates Combined   

<table><tr><td rowspan=1 colspan=1>ClinicalDetermination</td><td rowspan=1 colspan=1>VIRTUOTruePositives</td><td rowspan=1 colspan=1>% of VIRTUOTrue Positives inPopulation</td><td rowspan=1 colspan=1>BTA3DTruePositives</td><td rowspan=1 colspan=1>% of BTA3DTrue Positives inPopulation</td><td rowspan=1 colspan=1>Ratio ofTruePositives(VIRTUO/BTA3D)</td><td rowspan=1 colspan=1>95%CI(LCL,UCL)</td></tr><tr><td rowspan=1 colspan=1>Significant</td><td rowspan=1 colspan=1>47</td><td rowspan=1 colspan=1>5.2 (47/912)</td><td rowspan=1 colspan=1>48</td><td rowspan=1 colspan=1>5.3 (48/912)</td><td rowspan=1 colspan=1>0.979</td><td rowspan=1 colspan=1>0.823,1.135</td></tr><tr><td rowspan=1 colspan=1>Contaminant</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>1.4 (13/912)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>1.1 (10/912)</td><td rowspan=1 colspan=1>1.300</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Unknown</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0 (0/912)</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0 (0/912)</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>6.6 (60/912)</td><td rowspan=1 colspan=1>58</td><td rowspan=1 colspan=1>6.4 (58/912)</td><td rowspan=1 colspan=1>1.034</td><td rowspan=1 colspan=1>0.852,1.216</td></tr></table>

\* Confidence intervals not calculated due to small sample size.

Table 29. FN Plus – Blood – Single Isolates   

<table><tr><td rowspan=1 colspan=1>ClinicalDetermination</td><td rowspan=1 colspan=1>VIRTUOTruePositives</td><td rowspan=1 colspan=1>% of VIRTUOTrue Positives inPopulation</td><td rowspan=1 colspan=1>BTA3DTruePositives</td><td rowspan=1 colspan=1>% of BTA3DTrue Positives inPopulation</td><td rowspan=1 colspan=1>Ratio ofTruePositives(VIRTUO/BTA3D)</td><td rowspan=1 colspan=1>95%CI(LCL,UCL</td></tr><tr><td rowspan=1 colspan=1>Significant</td><td rowspan=1 colspan=1>39</td><td rowspan=1 colspan=1>4.3 (39/901)</td><td rowspan=1 colspan=1>43</td><td rowspan=1 colspan=1>4.8 (43/901)</td><td rowspan=1 colspan=1>0.907</td><td rowspan=1 colspan=1>0.757,1.057</td></tr><tr><td rowspan=1 colspan=1>Contaminant</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>1.1 (10/901)</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>0.8 (7/901)</td><td rowspan=1 colspan=1>1.429</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Unknown</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0 (0/901)</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0 (0/901)</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>49</td><td rowspan=1 colspan=1>5.4 (49/901)</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>5.5 (50/901)</td><td rowspan=1 colspan=1>0.980</td><td rowspan=1 colspan=1>0.786,1.174</td></tr></table>

\* Confidence intervals not calculated due to small sample size.

Table 30. FN Plus – Blood – Multiple Isolates   

<table><tr><td rowspan=1 colspan=1>ClinicalDetermination</td><td rowspan=1 colspan=1>VIRTUOTruePositives</td><td rowspan=1 colspan=1>% of VIRTUOTrue Positives inPopulation</td><td rowspan=1 colspan=1>BTA3DTruePositives</td><td rowspan=1 colspan=1>% of BTA3DTrue Positives inPopulation</td><td rowspan=1 colspan=1>Ratio ofTruePositives(VIRTUO/BTA3D)</td><td rowspan=1 colspan=1>95%CI(LCL,UCL)</td></tr><tr><td rowspan=1 colspan=1>Significant</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>72.7 (8/11)</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>45.5 (5/11)</td><td rowspan=1 colspan=1>1.600</td><td rowspan=1 colspan=1>0.741,2.459</td></tr><tr><td rowspan=1 colspan=1>Contaminant</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>27.3 (3/11)</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>27.3 (3/11)</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Unknown</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0 (0/11)</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0 (0/11)</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>100.0 (11/11)</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>72.7 (8/11)</td><td rowspan=1 colspan=1>1.375</td><td rowspan=1 colspan=1>0.877,1.873</td></tr></table>

\* Confidence intervals not calculated due to small sample size.

Table 31 includes the comparative yield of microorganisms (number of isolates) recovered on subculture from FN Plus bottles incubated on VIRTUO and BTA3D.

Table 31. FN Plus: Comparative Yield of Microorganisms (Number of Isolates) – Blood Cultures   

<table><tr><td rowspan=1 colspan=1>Group</td><td rowspan=1 colspan=1>BacT/ALERTVIRTUO</td><td rowspan=1 colspan=1>BacT/ALERT 3D</td></tr><tr><td rowspan=1 colspan=1>Anaerobes</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Enterobacteriaceae</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>19</td></tr><tr><td rowspan=1 colspan=1>Enterococcus spp.</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>6</td></tr><tr><td rowspan=1 colspan=1>Yeasts</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>-</td></tr><tr><td rowspan=1 colspan=1>Non-fermentative Gram-Negative Bacilli</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Other Gram-Positive</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>-</td></tr><tr><td rowspan=1 colspan=1>Coagulase-Negative Staphylococcus</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>11</td></tr><tr><td rowspan=1 colspan=1>Staphylococcus aureus</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>13</td></tr><tr><td rowspan=1 colspan=1>Streptococcus spp.</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>8</td></tr><tr><td rowspan=1 colspan=1>All</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>58</td></tr></table>

NOTE: Isolate table includes polymicrobic cultures.

# Section M.2.I.c- PF Plus Bottles (Blood) Clinical Performance:

A total of 202 PF Plus bottle pairs, obtained from 73 pediatric patients suspected of blood stream bacterial/yeast infections were tested on both VIRTUO and BTA 3D instruments. Of these, 161 bottle pairs from 62 patients were determined as compliant. Two isolates were recovered from compliant positive bottle pairs with one isolate recovered on VIRTUO and another isolate recovered on BTA 3D. A total of 159 compliant bottle pairs were negative on both VIRTUO and BTA 3D.

One false positive PF Plus Culture Bottle was observed on VIRTUO (1/161, $0 . 6 2 \%$ ). No false positive PF Plus Culture Bottles were observed on BTA 3D.

Terminal subcultures were performed for 50 PF Plus bottle pairs that were negative on both VIRTUO and BTA 3D and no false negative results were observed for VIRTUO or

BTA 3D.

Table 32 compares true positive results of compliant PF Plus blood cultures incubated on VIRTUO and BTA 3D that yielded any number of isolates on subculture.

Table 32: PF Plus - Blood - Compliant – Single and Multiple Isolates Combined   

<table><tr><td rowspan=1 colspan=1>ClinicalDetermination</td><td rowspan=1 colspan=1>VIRTUOTruePositives</td><td rowspan=1 colspan=1>% of VIRTUOTrue Positives inPopulation</td><td rowspan=1 colspan=1>BTA3DTruePositives</td><td rowspan=1 colspan=1>% of BTA3DTrue Positives inPopulation</td><td rowspan=1 colspan=1>Ratio ofTruePositives(VIRTUO/BTA3D)</td><td rowspan=1 colspan=1>95% CI(LCL,UCL)</td></tr><tr><td rowspan=1 colspan=1>Significant</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>0.6 (1/161)</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>0.6 (1/161)</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>-1.772,3.772*</td></tr><tr><td rowspan=1 colspan=1>Contaminant</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0 (0/161)</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0 (0/161)</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>**</td></tr><tr><td rowspan=1 colspan=1>Unknown</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0 (0/161)</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0 (0/161)</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>**</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0.6 (1/161)</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0.6 (1/161)</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>-1.772,3.772*</td></tr></table>

\*not statistically relevant due to the small sample size $^ { * * }$ Confidence intervals not calculated due to small sample size.

# Section M.2.I.d- Low-Fill FA Plus Bottles (Surrogate for PF Plus bottles) Clinical Performance:

PF Plus bottles contain the same media composition as FA Plus bottles with the only difference being the required blood volume described in labeling and use in the clinical setting. Due to the low numbers of positive PF Plus bottles observed in the clinical study and in order to further compare the performance of VIRTUO and BTA 3D instruments for low volumes that would typically be collected from pediatric patients using PF Plus Culture Bottles, an evaluation was performed with low-fill FA Plus Culture Bottles (from adult patients) inoculated with blood volumes of ${ \le } 4 ~ \mathrm { m L }$ .

A total of 550 FA Plus bottle pairs with ${ < } 4 ~ \mathrm { m L }$ blood fill volumes were tested on VIRTUO and BTA 3D. Of these, 379 bottle pairs from 292 adult patients had compliant fill volumes. A total of 40 isolates were recovered from all compliant low-fill FA Plus blood culture pairs with a positive status. A total of 33 isolates were recovered from lowfill FA Plus Culture Bottles on VIRTUO and 32 isolates were recovered from low-fill FA Plus Culture Bottles on BTA 3D. Of the significant isolates, the VIRTUO FA Plus Culture Bottle detected a total of 28 isolates compared to the BTA 3D Culture Bottle which detected 29 isolates.

No false positive low-fill FA Plus bottles were observed for VIRTUO or BTA 3D.

Terminal subcultures were performed for 246 low-fill FA Plus bottle pairs that were negative on both VIRTUO and BTA 3D. No false negative results were observed for bottles incubated on either instrument.

Table 33 compares results for VIRTUO and BTA 3D for all compliant low-fill FA Plus blood culture bottle pairs. No compliant low-fill FA Plus bottle pairs with a positive status yielded multiple isolates on subculture.

Table 33 Low Fill FA Plus - Blood – Compliant –Single Isolates   

<table><tr><td rowspan=1 colspan=1>ClinicalDetermination</td><td rowspan=1 colspan=1>VIRTUOTruePositives</td><td rowspan=1 colspan=1>% of VIRTUOTrue Positives inPopulation</td><td rowspan=1 colspan=1>BTA3DTruePositives</td><td rowspan=1 colspan=1>% of BTA3DTrue Positives inPopulation</td><td rowspan=1 colspan=1>Ratio ofTruePositives(VIRTUO/BTA3D)</td><td rowspan=1 colspan=1>95%CI(LCL,UCL)</td></tr><tr><td rowspan=1 colspan=1>Significant</td><td rowspan=1 colspan=1>28</td><td rowspan=1 colspan=1>7.4 (28/379)</td><td rowspan=1 colspan=1>29</td><td rowspan=1 colspan=1>7.7 (29/379)</td><td rowspan=1 colspan=1>0.966</td><td rowspan=1 colspan=1>0.790,1.142</td></tr><tr><td rowspan=1 colspan=1>Contaminant</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>1.1 (4/379)</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0.8 (3/379)</td><td rowspan=1 colspan=1>1.333</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Unknown</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0.3 (1/379)</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0 (0/379)</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>33</td><td rowspan=1 colspan=1>8.7 (33/379)</td><td rowspan=1 colspan=1>32</td><td rowspan=1 colspan=1>8.4 (32/379)</td><td rowspan=1 colspan=1>1.031</td><td rowspan=1 colspan=1>0.790,1.272</td></tr></table>

\* Confidence intervals not calculated due to small sample size.

Table 34 includes the comparative yield of microorganisms (number of isolates) recovered on subculture from compliant Low Fill FA Plus culture bottles.

Table 34. Low Fill FA Plus - Comparative Yield of Microorganisms (Number of Isolates)   

<table><tr><td rowspan=1 colspan=1>Group</td><td rowspan=1 colspan=1>BacT/ALERTVIRTUO</td><td rowspan=1 colspan=1>BacT/ALERT 3D</td></tr><tr><td rowspan=1 colspan=1>Enterobacteriaceae</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>9</td></tr><tr><td rowspan=1 colspan=1>Enterococcus spp.</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Yeasts</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Non-fermentative Gram-Negative Bacilli</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Other Gram-Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Coagulase-Negative Staphylococcus</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>5</td></tr><tr><td rowspan=1 colspan=1>Staphylococcus aureus</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>7</td></tr><tr><td rowspan=1 colspan=1>Streptococcus spp.</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>5</td></tr><tr><td rowspan=1 colspan=1>Other</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>All</td><td rowspan=1 colspan=1>33</td><td rowspan=1 colspan=1>32</td></tr></table>

NOTE: Isolate table includes polymicrobic cultures.

# Section M.2.I.e- SA Bottles (Blood) Clinical Performance:

A total of 1046 SA bottle pairs, obtained from 508 adult patients suspected of blood stream bacterial/yeast infections were tested on both VIRTUO and BTA 3D instruments. Of these, 776 bottle pairs from 440 adult patients were determined to be compliant.

A total of 60 isolates were recovered by subculture from all compliant SA Culture Bottle pairs with a positive status. At least one isolate was recovered from a total of 56 bottle pairs with a single isolate recovered from 52 bottle pairs and two isolates recovered from four bottle pairs.

A total of 46 isolates were recovered from SA Culture Bottles on VIRTUO and a total of

50 isolates were recovered from SA Culture Bottles on BTA 3D. Of the significant isolates, the VIRTUO SA Culture Bottles detected a total of 40 isolates compared to the BTA 3D SA Culture Bottles which detected 39 isolates.

Two false positive SA Culture Bottles were observed on VIRTUO (2/780, $0 . 2 6 \%$ ) and three false positive SA Bottles were observed on BTA 3D (3/780, $0 . 3 8 \%$ .

Terminal subcultures were performed for 779 SA Culture Bottle pairs that were negative on both VIRTUO and BTA 3D. Five false negative bottles were observed for FN Plus Culture Bottles on both VIRTUO and BTA 3D. For negative bottle pairs that were subcultured, the final false negative rate was $0 . 6 4 \%$ (5/779) for both instruments.

The following tables compare results of true positive blood cultures incubated on VIRTUO and BTA 3D for all compliant SA Culture Bottles yielding any number of isolates on subculture (Table 35), a single isolate on subculture (Table 36), and multiple isolates on subculture (Table 37).

Table 35. SA Bottles - Blood Culture – Compliant – Single and Multiple Isolates   

<table><tr><td rowspan=1 colspan=1>ClinicalDetermination</td><td rowspan=1 colspan=1>VIRTUOTruePositives</td><td rowspan=1 colspan=1>% of VIRTUOTrue Positives inPopulation</td><td rowspan=1 colspan=1>BTA3DTruePositives</td><td rowspan=1 colspan=1>% of BTA3DTrue Positives inPopulation</td><td rowspan=1 colspan=1>Ratio ofTruePositives(VIRTUO/BTA3D)</td><td rowspan=1 colspan=1>95% CI(LCL,UCL</td></tr><tr><td rowspan=1 colspan=1>Significant</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>5.1 (40/780)</td><td rowspan=1 colspan=1>39</td><td rowspan=1 colspan=1>5.0 (39/780)</td><td rowspan=1 colspan=1>1.026</td><td rowspan=1 colspan=1>0.857,1.195</td></tr><tr><td rowspan=1 colspan=1>Contaminant</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>0.5 (4/780)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>1.3 (10/780)</td><td rowspan=1 colspan=1>0.400</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Unknown</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0.3 (2/780)</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0.1 (1/780)</td><td rowspan=1 colspan=1>2.000</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>46</td><td rowspan=1 colspan=1>5.9 (46/780)</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>6.4 (50/780)</td><td rowspan=1 colspan=1>0.920</td><td rowspan=1 colspan=1>0.736,1.104</td></tr></table>

\* Confidence intervals not calculated due to small sample size.

Table 36. SA Bottles– Blood Culture– Compliant - Single Isolates   

<table><tr><td rowspan=1 colspan=1>ClinicalDetermination</td><td rowspan=1 colspan=1>VIRTUOTruePositives</td><td rowspan=1 colspan=1>% of VIRTUOTrue Positives inPopulation</td><td rowspan=1 colspan=1>BTA3DTruePositives</td><td rowspan=1 colspan=1>% of BTA3DTrue Positives inPopulation</td><td rowspan=1 colspan=1>Ratio ofTruePositives(VIRTUO/BTA3D)</td><td rowspan=1 colspan=1>95% CI(LCL,UCL</td></tr><tr><td rowspan=1 colspan=1>Significant</td><td rowspan=1 colspan=1>33</td><td rowspan=1 colspan=1>4.3 (33/772)</td><td rowspan=1 colspan=1>32</td><td rowspan=1 colspan=1>4.1 (32/772)</td><td rowspan=1 colspan=1>1.031</td><td rowspan=1 colspan=1>0.825,1.237</td></tr><tr><td rowspan=1 colspan=1>Contaminant</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>0.5 (4/772)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>1.3 (10/772)</td><td rowspan=1 colspan=1>0.400</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Unknown</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0.1 (1/772)</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0 (0/772)</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>38</td><td rowspan=1 colspan=1>4.9 (38/772)</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>5.4 (42/772)</td><td rowspan=1 colspan=1>0.905</td><td rowspan=1 colspan=1>0.688,1.122</td></tr></table>

\* Confidence intervals not calculated due to small sample size.

Table 37. SA Bottles – Blood Culture – Compliant - Multiple Isolates   

<table><tr><td rowspan=1 colspan=1>ClinicalDetermination</td><td rowspan=1 colspan=1>VIRTUOTruePositives</td><td rowspan=1 colspan=1>% of VIRTUOTrue Positives inPopulation</td><td rowspan=1 colspan=1>BTA3DTruePositives</td><td rowspan=1 colspan=1>% of BTA3DTrue Positives inPopulation</td><td rowspan=1 colspan=1>Ratio ofTruePositives(VIRTUO/BTA3D)</td><td rowspan=1 colspan=1>95% CI(LCL,UCL)</td></tr><tr><td rowspan=1 colspan=1>Significant</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>87.5 (7/8)</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>87.5 (7/8)</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>1.000,1.000</td></tr><tr><td rowspan=1 colspan=1>Contaminant</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0 (0/8)</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0 (0/8)</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Unknown</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>12.5 (1/8)</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>12.5 (1/8)</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>100.0 (8/8)</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>100.0 (8/8)</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>1.000,1.000</td></tr></table>

\* Confidence intervals not calculated due to small sample size.

Table 38 includes the comparative yield of microorganisms (number of isolates) recovered on subculture from compliant SA Culture Bottles.

Table 38. SA Bottles - Comparative Yield of Microorganisms From VIRTUO and BTA 3D (Number of Isolates) – Blood Cultures   

<table><tr><td rowspan=1 colspan=1>Group</td><td rowspan=1 colspan=1>BacT/ALERTVIRTUO</td><td rowspan=1 colspan=1>BacT/ALERT 3D</td></tr><tr><td rowspan=1 colspan=1>Enterobacteriaceae</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>12</td></tr><tr><td rowspan=1 colspan=1>Enterococcus spp.</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>7</td></tr><tr><td rowspan=1 colspan=1>Yeasts</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Non-fermentative Gram-Negative Bacilli</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>5</td></tr><tr><td rowspan=1 colspan=1>Other Gram-Positive</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Coagulase-Negative Staphylococcus</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>17</td></tr><tr><td rowspan=1 colspan=1>Staphylococcus aureus</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>4</td></tr><tr><td rowspan=1 colspan=1>Streptococcus spp.</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>All</td><td rowspan=1 colspan=1>46</td><td rowspan=1 colspan=1>50</td></tr></table>

NOTE: Isolate table includes polymicrobic cultures.

# Section M.2.I.f- SN Bottles (Blood) – Clinical Performance:

A total of 1061 SN bottle pairs, obtained from 456 adult patients suspected of blood stream bacterial/yeast infections were tested on both VIRTUO and BTA 3D. Of these, 826 bottle pairs from 394 patients were determined as compliant.

A total of 45 isolates were recovered from all compliant SN Culture Bottle pairs with a positive status. At least one isolate was recovered by subculture from 41 SN bottle pairs incubated on VIRTUO or BTA 3D instruments. A single isolate was recovered from 38 bottle pairs, two isolates were recovered from 2 bottle pairs, and three isolates were recovered from 1 bottle pair.

The total population reported in Table 39 below comprises the 45 isolates recovered from positive bottle pairs and 785 negative bottle pairs for a total of 830 results. A total of 34 isolates were recovered from SN Culture Bottles on VIRTUO and a total of 34 isolates were recovered from SN Culture Bottles on BTA 3D. For significant isolates, 32 were recovered from SN Culture Bottles on VIRTUO and 30 were recovered from SN Culture Bottles on BTA 3D.

There were no false positive SN Culture Bottles on VIRTUO (0/830) and four false positive SN Culture Bottles on BTA 3D (4/830, $0 . 4 8 \% )$ .

Terminal subcultures were performed for $9 3 5 \mathrm { S N }$ bottle pairs that were negative on both VIRTUO and BTA 3D. For bottle pairs where both negative bottles were subcultured, the final false negative rate for SN bottles was $0 . 4 3 \%$ (4/935) for each instrument.

The following tables compare results of true positive blood cultures incubated on VIRTUO and BTA 3D for all compliant SN bottles yielding any number of isolates on subculture (Table 39), a single isolate on subculture (Table 40), and multiple isolates on subculture (Table 41).

Table 39: SN Bottles - Blood – Compliant – Single and Multiple Isolates   

<table><tr><td rowspan=1 colspan=1>ClinicalDetermination</td><td rowspan=1 colspan=1>VIRTUOTruePositives</td><td rowspan=1 colspan=1>% of VIRTUOTrue Positives inPopulation</td><td rowspan=1 colspan=1>BTA3DTruePositives</td><td rowspan=1 colspan=1>% of BTA3DTrue Positives inPopulation</td><td rowspan=1 colspan=1>Ratio ofTruePositives(VIRTUO/BTA3D)</td><td rowspan=1 colspan=1>95% CI(LCL,UCL</td></tr><tr><td rowspan=1 colspan=1>Significant</td><td rowspan=1 colspan=1>32</td><td rowspan=1 colspan=1>3.9 (32/830)</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>3.6 (30/830)</td><td rowspan=1 colspan=1>1.067</td><td rowspan=1 colspan=1>0.797,1.337</td></tr><tr><td rowspan=1 colspan=1>Contaminant</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0.1 (1/830)</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>0.5 (4/830)</td><td rowspan=1 colspan=1>0.250</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Unknown</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0.1 (1/830)</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0 (0/830)</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>34</td><td rowspan=1 colspan=1>4.1 (34/830)</td><td rowspan=1 colspan=1>34</td><td rowspan=1 colspan=1>4.1 (34/830)</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>0.730,1.270</td></tr></table>

\* Confidence intervals not calculated due to small sample size.

Table 40. SN Bottles - Blood – Compliant - Single Isolates   

<table><tr><td rowspan=1 colspan=1>ClinicalDetermination</td><td rowspan=1 colspan=1>VIRTUOTruePositives</td><td rowspan=1 colspan=1>% of VIRTUOTrue Positives inPopulation</td><td rowspan=1 colspan=1>BTA3DTruePositives</td><td rowspan=1 colspan=1>% of BTA3DTrue Positives inPopulation</td><td rowspan=1 colspan=1>Ratio ofTruePositives(VIRTUO/BTA3D)</td><td rowspan=1 colspan=1>95% CI(LCL,UCL</td></tr><tr><td rowspan=1 colspan=1>Significant</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>3.0 (25/823)</td><td rowspan=1 colspan=1>24</td><td rowspan=1 colspan=1>2.9 (24/823)</td><td rowspan=1 colspan=1>1.042</td><td rowspan=1 colspan=1>0.719,1.365</td></tr><tr><td rowspan=1 colspan=1>Contaminant</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0.1 (1/823)</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>0.5 (4/823)</td><td rowspan=1 colspan=1>0.250</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Unknown</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0.1 (1/823)</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0 (0/823)</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>27</td><td rowspan=1 colspan=1>3.3 (27/823)</td><td rowspan=1 colspan=1>28</td><td rowspan=1 colspan=1>3.4 (28/823)</td><td rowspan=1 colspan=1>0.964</td><td rowspan=1 colspan=1>0.649,1.279</td></tr></table>

\* Confidence intervals not calculated due to small sample size.

Table 41. SN Bottles - Blood – Compliant - Multiple Isolates   

<table><tr><td rowspan=1 colspan=1>ClinicalDetermination</td><td rowspan=1 colspan=1>VIRTUOTruePositives</td><td rowspan=1 colspan=1>% of VIRTUOTrue Positivesin Population</td><td rowspan=1 colspan=1>BTA3DTruePositives</td><td rowspan=1 colspan=1>% of BTA3DTrue Positivesin Population</td><td rowspan=1 colspan=1>Ratio ofTruePositives(VIRTUO/BTA3D)</td><td rowspan=1 colspan=1>95% CI(LCL,UCL)</td></tr><tr><td rowspan=1 colspan=1>Significant</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>100.0 (7/7)</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>85.7 (6/7)</td><td rowspan=1 colspan=1>1.167</td><td rowspan=1 colspan=1>0.814,1.520</td></tr><tr><td rowspan=1 colspan=1>Contaminant</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0 (0/7)</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0 (0/7)</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Unknown</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0 (0/7)</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0 (0/7)</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>100.0 (7/7)</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>85.7 (6/7)</td><td rowspan=1 colspan=1>1.167</td><td rowspan=1 colspan=1>0.814,1.520</td></tr></table>

\* Confidence intervals not calculated due to small sample size.

Table 42 includes the comparative yield of microorganisms (number of isolates) recovered on subculture from compliant SN bottles.

Table 42. SN Bottles - Comparative Yield of Microorganisms (Number of Isolates) – Blood Cultures   

<table><tr><td rowspan=1 colspan=1>Group</td><td rowspan=1 colspan=1>BacT/ALERTVIRTUO</td><td rowspan=1 colspan=1>BacT/ALERT 3D</td></tr><tr><td rowspan=1 colspan=1>Anaerobes</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>4</td></tr><tr><td rowspan=1 colspan=1>Enterobacteriaceae</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>8</td></tr><tr><td rowspan=1 colspan=1>Enterococcus spp.</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>7</td></tr><tr><td rowspan=1 colspan=1>Yeasts</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>3</td></tr><tr><td rowspan=1 colspan=1>Non-fermentative Gram-Negative Bacilli</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Other Gram-Positive</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Coagulase-Negative Staphylococcus</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>5</td></tr><tr><td rowspan=1 colspan=1>Staphylococcus aureus</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Streptococcus spp.</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>All</td><td rowspan=1 colspan=1>34</td><td rowspan=1 colspan=1>34</td></tr></table>

NOTE: Isolate table includes polymicrobic cultures.

In summary, the clinical study results demonstrate equivalent performance for paired blood culture specimens in FA Plus, FN Plus, PF Plus, SA, and SN Culture Bottles tested on VIRTUO and BTA3D Systems.

# Section M.2.II- Clinical Study to Evaluate Sterile Body Fluid Cultures (SBF) on VIRTUO and BTA 3D:

A multi-center clinical study was conducted comparing the performance of the VIRTUO and BTA 3D systems using FA Plus, FN Plus, SA, and SN bottles inoculated with SBF specimens. SBF specimen types evaluated included continuous ambulatory peritoneal dialysis (CAPD) fluid, cerebrospinal fluid (CSF), pericardial fluid, peritoneal fluid, pleural fluid, and synovial fluid. Recovered clinical isolates were classified as significant, contaminant or unknown based on determination by the clinical trial sites. Regardless of specimen inoculum volume, all bottle pairs were considered compliant and included in the performance analysis.

# Section M.2.II.a- FA Plus Culture Bottles (SBF):

A total of 362 FA Plus bottle pairs inoculated with SBF specimens obtained from 284 adult patients were tested on both VIRTUO and BTA 3D instruments. A total of 66 isolates were recovered from all FA Plus Culture Bottle pairs with a positive status. There were 54 bottle pairs with at least one isolate recovered by subculture of FA Plus Culture Bottles incubated on either VIRTUO or BTA 3D instruments. One isolate was recovered from 46 bottle pairs, two isolates were recovered from each of five bottle pairs, three isolates were recovered from each of two bottle pairs, and 4 isolates were recovered from one bottle pair.

Table 43 below shows results for true positive bottles yielding any number of isolates from subculture. A total of 55 isolates were recovered from FA Plus Culture Bottles incubated on VIRTUO and 52 isolates were recovered from FA Plus Culture Bottles incubated on BTA 3D. Of the significant isolates, 42 isolates were recovered from FA Plus bottles incubated on both instruments.

No false positives were identified for bottles incubated on VIRTUO or BTA 3D (0/374 for each instrument).

Table 43. FA Plus – SBF - Single and Multiple Isolates   

<table><tr><td rowspan=1 colspan=1>ClinicalDetermination</td><td rowspan=1 colspan=1>VIRTUOTruePositives</td><td rowspan=1 colspan=1>% of VIRTUOTrue Positives inPopulation</td><td rowspan=1 colspan=1>BTA3DTruePositives</td><td rowspan=1 colspan=1>% of BTA3DTrue Positives inPopulation</td><td rowspan=1 colspan=1>Ratio ofTruePositives(VIRTUO/BTA3D)</td><td rowspan=1 colspan=1>95% CI(LCL,UCL</td></tr><tr><td rowspan=1 colspan=1>Significant</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>11.2 (42/374)</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>11.2 (42/374)</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>0.852,1.148</td></tr><tr><td rowspan=1 colspan=1>Contaminant</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>2.1 (8/374)</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>1.6 (6/374)</td><td rowspan=1 colspan=1>1.333</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Unknown</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>1.3 (5/374)</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>1.1 (4/374)</td><td rowspan=1 colspan=1>1.250</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>55</td><td rowspan=1 colspan=1>14.7 (55/374)</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>13.9 (52/374)</td><td rowspan=1 colspan=1>1.058</td><td rowspan=1 colspan=1>0.864,1.252</td></tr></table>

\* Confidence intervals not calculated due to small sample size.

Table 44 includes the comparative yield of microorganisms (number of isolates) recovered on subculture from FA Plus bottles containing SBF. Table 45 includes the number of positive specimens by fluid type.

Table 44. FA Plus - Comparative Yield of Microorganisms (Number of Isolates) – Sterile Body Fluid Cultures   

<table><tr><td rowspan=1 colspan=1>Group</td><td rowspan=1 colspan=1>BacT/ALERTVIRTUO</td><td rowspan=1 colspan=1>BacT/ALERT 3D</td></tr><tr><td rowspan=1 colspan=1>Anaerobes</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>-</td></tr><tr><td rowspan=1 colspan=1>Enterobacteriaceae</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td></tr><tr><td rowspan=1 colspan=1>Enterococcus spp.</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>5</td></tr><tr><td rowspan=1 colspan=1>Yeasts</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>4</td></tr><tr><td rowspan=1 colspan=1>Non-fermentative Gram-Negative Bacilli</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>5</td></tr><tr><td rowspan=1 colspan=1>Other Gram-Negative</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Other Gram-Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Coagulase-Negative Staphylococcus</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>6</td></tr><tr><td rowspan=1 colspan=1>Staphylococcus aureus</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>3</td></tr><tr><td rowspan=1 colspan=1>Streptococcus spp.</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>12</td></tr><tr><td rowspan=1 colspan=1>All</td><td rowspan=1 colspan=1>55</td><td rowspan=1 colspan=1>52</td></tr></table>

NOTE: Isolate table includes polymicrobic cultures.

Table 45. FA Plus -Number of Positive Specimens – Sterile Body Fluid Cultures   

<table><tr><td rowspan=1 colspan=1>Sterile Body Fluid Type</td><td rowspan=1 colspan=1>BacT/ALERTVIRTUO</td><td rowspan=1 colspan=1>BacT/ALERT 3D</td></tr><tr><td rowspan=1 colspan=1>CAPD</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Pericardial</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Peritoneal</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>21</td></tr><tr><td rowspan=1 colspan=1>Pleural</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>19</td></tr><tr><td rowspan=1 colspan=1>Synovial</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>5</td></tr></table>

# Section M.2.II.b - FN Plus Culture Bottles (SBF):

A total of 419 FN Plus bottle pairs inoculated with SBF specimens obtained from 333 adult patients were tested on both VIRTUO and BTA 3D instruments. A total of 67 isolates were recovered from all FN Plus Culture Bottle pairs with a positive status. There were 52 bottle pairs with at least 1 isolate recovered by subculture from FN Plus bottles incubated on either VIRTUO or BTA 3D instruments. One isolate was recovered from 42 bottle pairs, two isolates were recovered from six bottle pairs and three isolates were recovered from three bottle pairs and four isolates were recovered from one bottle pair.

Table 46 below shows results for true positive bottles yielding any number of isolates from subculture. A total of 52 isolates were recovered from FN Plus bottles incubated on VIRTUO and 52 isolates were recovered from FN Plus bottles incubated on BTA 3D. Of the significant isolates, 39 isolates were recovered from FN Plus bottles incubated on VIRTUO and 38 isolates were recovered from FN Plus bottles incubated on BTA 3D.

No false positives were identified for FN Plus bottles incubated on VIRTUO or BTA 3D (0/374) for each instrument).

Terminal subcultures were performed for 293 pairs of negative FN Plus bottle pairs containing SBF specimens. Of these, six false negative bottles were observed for VIRTUO and for BTA 3D (6/293, $2 . 0 5 \%$ for both instruments). For the six false negative bottle pairs, the organisms recovered from subculture were strict aerobes (Achromobacter denitrificans and Achromobacter xylosoxidans (2), Candida albicans (1), Candida albicans and Candida dubliniensis (1), Candida krusei (2)). It is noted that the FN Plus bottles are not designed for recovery of aerobic bacteria.

Table 46. FN Plus - Sterile Body Fluids - Single and Multiple Isolates   

<table><tr><td rowspan=1 colspan=1>ClinicalDetermination</td><td rowspan=1 colspan=1>VIRTUOTruePositives</td><td rowspan=1 colspan=1>% of VIRTUOTrue Positivesin Population</td><td rowspan=1 colspan=1>BTA3DTruePositives</td><td rowspan=1 colspan=1>% of BTA3DTrue Positivesin Population</td><td rowspan=1 colspan=1>Ratio ofTruePositives</td><td rowspan=1 colspan=1>95% CI(LCL,UCL</td></tr><tr><td rowspan=1 colspan=1>Significant</td><td rowspan=1 colspan=1>39</td><td rowspan=1 colspan=1>8.9 (39/437)</td><td rowspan=1 colspan=1>38</td><td rowspan=1 colspan=1>8.7 (38/437)</td><td rowspan=1 colspan=1>1.026</td><td rowspan=1 colspan=1>0.838,1.214</td></tr><tr><td rowspan=1 colspan=1>Contaminant</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>2.1 (9/437)</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>1.8 (8/437)</td><td rowspan=1 colspan=1>1.125</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Unknown</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>0.9 (4/437)</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>1.4 (6/437)</td><td rowspan=1 colspan=1>0.667</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>11.9 (52/437)</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>11.9 (52/437)</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>0.794,1.206</td></tr></table>

\* Confidence intervals not calculated due to small sample size.

Table 47 includes the comparative yield of microorganisms (number of isolates) recovered on subculture from FN Plus bottles containing SBF. Table 48 includes the number of positive specimens by fluid type.

Table 47. FN Plus - Comparative Yield of Microorganisms (Number of Isolates) – Sterile Body Fluid Cultures   

<table><tr><td rowspan=1 colspan=1>Group</td><td rowspan=1 colspan=1>BacT/ALERTVIRTUO</td><td rowspan=1 colspan=1>BacT/ALERT 3D</td></tr><tr><td rowspan=1 colspan=1>Anaerobes</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Enterobacteriaceae</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>15</td></tr><tr><td rowspan=1 colspan=1>Enterococcus spp.</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>8</td></tr><tr><td rowspan=1 colspan=1>Yeasts</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Non-fermentative Gram-Negative Bacilli</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Other Gram-Positive</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Coagulase-Negative Staphylococcus</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>7</td></tr><tr><td rowspan=1 colspan=1>Staphylococcus aureus</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>5</td></tr><tr><td rowspan=1 colspan=1>Streptococcus spp.</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>12</td></tr><tr><td rowspan=1 colspan=1>All</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>52</td></tr></table>

NOTE: Isolate table includes polymicrobic cultures.

Table 48. FN Plus - Number of Positive Specimens – Sterile Body Fluid Cultures   

<table><tr><td rowspan=1 colspan=1>Sterile Body Fluid Type</td><td rowspan=1 colspan=1>BacT/ALERTVIRTUO</td><td rowspan=1 colspan=1>BacT/ALERT 3D</td></tr><tr><td rowspan=1 colspan=1>CAPD</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Pericardial</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Peritoneal</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>21</td></tr><tr><td rowspan=1 colspan=1>Pleural</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>16</td></tr><tr><td rowspan=1 colspan=1>Synovial</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>4</td></tr></table>

# Section M.2.II.c: SA Culture Bottles (SBF)

A total of 75 SA bottle pairs inoculated with SBF specimens obtained from 71 adult patients were tested on both VIRTUO and BTA 3D instruments with 18 isolates were recovered from all SA bottle pairs with a positive status. There were 16 bottle pairs with at least 1 isolate recovered by subculture from SA bottles incubated on either VIRTUO or BTA 3D. One isolate was recovered from 15 bottle pairs and 3 isolates were recovered from 1 bottle pair.

Table 49 below shows results for true positive bottles yielding any number of isolates from subculture. A total of 15 isolates were recovered from SA bottles incubated on VIRTUO and 17 isolates were recovered from SA bottles incubated on BTA 3D. Of the significant isolates, 14 isolates were recovered from SA bottles incubated on VIRTUO and 15 isolates were recovered from SA bottles incubated on BTA 3D.

No false positives were identified for SA bottles incubated on VIRTUO or BTA 3D (0/77) for each instrument).

Terminal subcultures were performed for 59 pairs of negative SA bottle pairs containing SBF specimens. There were no false negative results observed (0/59).

Table 49. SA Bottles - Sterile Body Fluids - Single and Multiple Isolates   

<table><tr><td rowspan=1 colspan=1>ClinicalDetermination</td><td rowspan=1 colspan=1>VIRTUOTruePositives</td><td rowspan=1 colspan=1>% of VIRTUOTrue Positivesin Population</td><td rowspan=1 colspan=1>BTA3DTruePositives</td><td rowspan=1 colspan=1>% of BTA3DTrue Positivesin Population</td><td rowspan=1 colspan=1>Ratio ofTruePositives</td><td rowspan=1 colspan=1>95%CI(LCL,UCL)</td></tr><tr><td rowspan=1 colspan=1>Significant</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>18.2 (14/77)</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>19.5 (15/77)</td><td rowspan=1 colspan=1>0.933</td><td rowspan=1 colspan=1>0.807,1.059</td></tr><tr><td rowspan=1 colspan=1>Contaminant</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0 (0/77)</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>2.6 (2/77)</td><td rowspan=1 colspan=1>0.000</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Unknown</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1.3 (1/77)</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0 (0/77)</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>19.5 (15/77)</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>22.1 (17/77)</td><td rowspan=1 colspan=1>0.882</td><td rowspan=1 colspan=1>0.665,1.099</td></tr></table>

\* Confidence intervals not calculated due to small sample size.

Table 50 includes the comparative yield of microorganisms (number of isolates) recovered on subculture from SA Plus bottles containing SBF. Table 51 includes the number of positive specimens by fluid type.

Table 50: Comparative Yield of Microorganisms (Number of Isolates) – Sterile Body Fluid Cultures   

<table><tr><td rowspan=1 colspan=1>Group</td><td rowspan=1 colspan=1>BacT/ALERTVIRTUO</td><td rowspan=1 colspan=1>BacT/ALERT 3D</td></tr><tr><td rowspan=1 colspan=1>Enterobacteriaceae</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>3</td></tr><tr><td rowspan=1 colspan=1>Enterococcus spp.</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Yeasts</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>-</td></tr><tr><td rowspan=1 colspan=1>Non-fermentative Gram-Negative Bacilli</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Other Gram-Positive</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Coagulase-Negative Staphylococcus</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>4</td></tr><tr><td rowspan=1 colspan=1>Staphylococcus aureus</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>3</td></tr><tr><td rowspan=1 colspan=1>Streptococcus spp.</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>All</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>17</td></tr></table>

NOTE: Isolate table includes polymicrobic cultures.

Table 51. SA Bottles - Number of Positive Specimens From BacT/ALERT VIRTUO and BacT/ALERT 3D – Sterile Body Fluid Cultures   

<table><tr><td rowspan=1 colspan=1>Sterile Body Fluid Type</td><td rowspan=1 colspan=1>BacT/ALERTVIRTUO</td><td rowspan=1 colspan=1>BacT/ALERT 3D</td></tr><tr><td rowspan=1 colspan=1>CAPD</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>3</td></tr><tr><td rowspan=1 colspan=1>Peritoneal</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>5</td></tr><tr><td rowspan=1 colspan=1>Pleural</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Synovial</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>6</td></tr></table>

# Section M.2.II.d- SN Culture Bottles (SBF):

A total of 75 SN bottle pairs inoculated with SBF specimens obtained from 71 adult patients were tested on both VIRTUO and BTA 3D instruments. A total of 21 isolates were recovered from all SN bottle pairs with a positive status. There were 10 bottle pairs with at least 1 isolate recovered by subculture; 4 bottle pairs with 2 isolates, and 1 bottle pair with 3 isolates.

Table 52 below shows results for true positive bottles yielding any number of isolates from subculture. A total of 19 isolates were recovered from SN bottles incubated on VIRTUO and 18 isolates were recovered from SN bottles incubated on BTA 3D. Of the significant isolates, 17 isolates were recovered from SN bottles incubated on each of the two instruments.

Terminal subcultures were performed for 61 pairs of negative SN bottle pairs containing SBF specimens. There were no false negative results observed (0/61).

No false positives were identified for SN bottles incubated on VIRTUO or BTA 3D (0/81) for each instrument).

Table 52. SN Bottles - Sterile Body Fluids - Single and Multiple Isolates   

<table><tr><td rowspan=1 colspan=1>ClinicalDetermination</td><td rowspan=1 colspan=1>VIRTUOTruePositives</td><td rowspan=1 colspan=1>% of VIRTUOTrue Positivesin Population</td><td rowspan=1 colspan=1>BTA3DTruePositives</td><td rowspan=1 colspan=1>% of BTA3DTrue Positivesin Population</td><td rowspan=1 colspan=1>Ratio ofTruePositives</td><td rowspan=1 colspan=1>95%CI(LCL,UCL</td></tr><tr><td rowspan=1 colspan=1>Significant</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>21.0 (17/81)</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>21.0 (17/81)</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>0.837,1.163</td></tr><tr><td rowspan=1 colspan=1>Contaminant</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1.2 (1/81)</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1.2 (1/81)</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Unknown</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1.2 (1/81)</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0 (0/81)</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>*</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>23.5 (19/81)</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>22.2 (18/81)</td><td rowspan=1 colspan=1>1.056</td><td rowspan=1 colspan=1>0.806,1.306</td></tr></table>

\* Confidence intervals not calculated due to small sample size.

Table 53 includes the comparative yield of microorganisms (number of isolates) recovered on subculture from SN bottles containing SBF. Table 54 includes the number of positive specimens by fluid type.

Table 53. SN Bottles - Comparative Yield of Microorganisms (Number of Isolates) – Sterile Body Fluid Cultures   

<table><tr><td rowspan=1 colspan=1>Group</td><td rowspan=1 colspan=1>BacT/ALERTVIRTUO</td><td rowspan=1 colspan=1>BacT/ALERT 3D</td></tr><tr><td rowspan=1 colspan=1>Anaerobes</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Enterobacteriaceae</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>4</td></tr><tr><td rowspan=1 colspan=1>Enterococcus spp.</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>Yeasts</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Non-fermentative Gram-Negative Bacilli</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>-</td></tr><tr><td rowspan=1 colspan=1>Other Gram-Positive</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>Coagulase-Negative Staphylococcus</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>4</td></tr><tr><td rowspan=1 colspan=1>Staphylococcus aureus</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>3</td></tr><tr><td rowspan=1 colspan=1>Streptococcus spp.</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>All</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>18</td></tr></table>

NOTE: Isolate table includes polymicrobic cultures.

Table 54. SN Bottles - Number of Positive Specimens From BacT/ALERT VIRTUO and BacT/ALERT 3D – Sterile Body Fluid Cultures   

<table><tr><td rowspan=1 colspan=1>Sterile Body Fluid Type</td><td rowspan=1 colspan=1>BacT/ALERTVIRTUO</td><td rowspan=1 colspan=1>BacT/ALERT 3D</td></tr><tr><td rowspan=1 colspan=1>CAPD</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>3</td></tr><tr><td rowspan=1 colspan=1>Peritoneal</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>5</td></tr><tr><td rowspan=1 colspan=1>Synovial</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>6</td></tr></table>

In summary, the clinical study results demonstrate equivalent performance for paired sterile fluid culture specimens in FA Plus, FN Plus, PF Plus, SA, and SN Culture Bottles tested on VIRTUO and BTA3D Systems.

3. Clinical studies:

a. Clinical Sensitivity:

Not applicable b. Clinical specificity: Not applicable

4. Clinical cut-off: Not applicable

5. Expected values/reference range:

The expected positive percentage of culture bottles will vary based on factors such as patient population, specimen type prevalence of significant organisms, site location, and contamination rates. The expected values shown below are based on the clinical study conducted to evaluate FA Plus, FN Plus, PF Plus, SA and SN Culture Bottles on the VIRTUO instrument for blood and SBF cultures:

FA Plus (Blood): Percent positive cultures were observed to be $6 . 2 \%$ (range: $4 . 7 \% 8 8 \%$ overall and $5 . 5 \%$ (range: $4 . 2 \% 8 . 5 \% )$ for significant isolates from three clinical trial sites in FA Plus Culture Bottles that received $\leq 1 0 ~ \mathrm { m L }$ of blood. FA Plus (SBF): Percent positive cultures were observed to be $1 3 . 3 \%$ (range: $9 . 2 \% - 1 7 . 4 \% )$ overall and $9 . 9 \%$ (range: $8 . 0 \% { - } 1 3 . 2 \%$ ) for significant isolates from three clinical trial sites in BacT/ALERT FA Plus Culture Bottles that received sterile body fluids.   
FN Plus (Blood): Percent positive cultures were observed to be $6 . 4 \%$ (range: $4 . 5 \% 6 . 6 \%$ overall and $5 . 2 \%$ (range: $4 . 5 \% - 5 . 6 \%$ ) for significant isolates from three clinical trial sites in FN Plus Culture Bottles that received $\leq 1 0 ~ \mathrm { m L }$ of blood. FN Plus (SBF): Percent positive cultures were observed to be $1 1 . 0 \%$ (range: $9 . 8 \% - 1 3 . 4 \% )$ overall and $8 . 1 \%$ (range: $7 . 3 \% 1 0 . 4 \%$ for significant isolates from three clinical trial sites in FN Plus Culture Bottles that received sterile body fluids.   
PF Plus (Blood): Percent positive cultures were observed to be $2 . 0 \%$ (range: $0 . 0 \% { - 2 . 1 \% }$ overall and $1 . 5 \%$ (range: $0 . 0 \% 1 . 6 \%$ ) for significant isolates from three clinical trial sites in PF Plus Culture Bottles that received $\leq 4 ~ \mathrm { m L }$ of blood. SA (Blood): Percent positive cultures were observed to be $5 . 5 \%$ (range: $5 . 5 \% \AA$ - $8 . 0 \%$ overall and $4 . 3 \%$ (range: $0 . 0 \% 6 4 . 4 \% )$ for significant isolates from two clinical trial sites in SA Culture Bottles that received $\leq 1 0 ~ \mathrm { m L }$ of blood. SA (SBF): Percent positive cultures were observed to be $1 7 . 3 \%$ overall and $1 7 . 3 \%$ for significant isolates from one clinical trial site in SA Culture Bottles that received sterile body fluids.   
SN (Blood): Percent positive cultures were observed to be $3 . 8 \%$ overall and $3 . 3 \%$ for significant isolates from one clinical trial site in BacT/ALERT SN Culture Bottles that received $\leq 1 0 ~ \mathrm { m L }$ of blood.   
SN (SBF): Percent positive cultures were observed to be $1 8 . 7 \%$ overall and $1 8 . 7 \%$ for significant isolates from one clinical trial site in BacT/ALERT SN Culture Bottles that received sterile body fluids.

# N. Instrument Name:

BacT/ALERT VIRTUO Microbial Detection System

# O. System Description:

1. Modes of Operation:

Does the applicant’s device contain the ability to transmit data to a computer, webserver, or mobile device?

Yes __X____ or No

Does the applicant’s device transmit data to a computer, webserver, or mobile device using wireless transmission?

Yes or No ___X_

Instrument System:

The VIRTUO Instrument consists of an incubator, agitation mechanism, and robotic apparatus for automated loading and unloading of bottles and a tactile graphical interface. The instrument configuration supports a single (A Unit) instrument or can have a bank of instruments (A Unit plus up to three B Units) that can stand alone or be connected to a customer network. Each instrument cabinet contains 16 racks with space for 27 bottles per rack for bottle monitoring. Four cells are dedicated for calibration standards. An instrument (either A Unit or B Unit) has a total capacity of 432 cells.

The instrument includes a Large Display screen where the operator can navigate through various operational function screens displaying items such as viewing of instrument status, cell availability, positive and negative bottles, alarms, and alerts. The instrument also includes a Small Display located above the bottle return chutes. This display is used to access specific instrument status information and maintenance functions.

FDA has reviewed applicant’s Hazard Analysis and software development processes for this line of product types:

Yes ___X____ or No

Level of Concern: Moderate

Software Description:

A detailed description of the VIRTUO software was provided describing the differences between the BTA 3D and the VIRTUO systems. The VIRTUO features a new database management system (MYLA). The MYLA controls the host and LIS interface, workflow management, result validation, data consolidation for archives, system and configuration data and remote notifications for alarms, configuration modifications and more.

# Device Hazard Analysis:

An updated risk assessment was provided including a VIRTUO instrumentation and software component risk analysis, a VIRTUO risk management summary, assessing product safety, VIRTUO System use and VIRTUO networking/connectivity. Risks of potential failures were assessed in terms of potential to harm the patient due to an incorrect result and the end user. Each potential failure and potential cause was assessed for severity, probability (as appropriate) and detectability before and after mitigation. After mitigation and assessment through validation studies (as appropriate), each risk was determined to be either minor or moderate (i.e., as low as reasonably possible).

Software Requirement Specifications (SRS):

Functional requirements for VIRTUO system configuration, alarm configuration/information signals, growth detection, information management, remote notification, customer remote access and manufacturer technical support were provided. Also provided were requirements for performance, operational, dependability, human factors, maintenance, transportation and storage, documentation, graphical user interface localization, physical characteristics, design and manufacturing, safety, and installation.

# Architecture Design Chart:

Detailed information was provided regarding the system architecture including flow charts for each of the system components. linking VIRTUO and MYLA system design specifications, (including detailed internal system designs and general component interfaces). Charts were provided for MYLA/VIRTUO interfaces detailing how connections are established, maintained and backed up. Charts for linked, networked and standalone configurations were provided.

# Traceability Analysis:

A traceability matrix was provided that tracks activities from system requirements to instrument and software design input to verification and validation of outputs for the VIRTUO, including usability and labeling. Details are referenced through a series of trace matrix documents for each component of the system.

Software Development Environment Description:

The software development life cycle plan provided describes the processes for input data, deliverables, controls and verifications for all elements of software development from design input to output validation. The documentation for the VIRTUO system was acceptable.

Verification and Validation (V&V):

Validation testing was provided for each specification for the VIRTUO instrument and software, including validation of hardware, installation, configuration, workflow, MYLA-LIS communication, data records, alarms/alerts, data storage, functionality at maximum capacity, remote testing, bottle authentication, temperature control, and priority processing.

# Revision Level History:

The software revision history record for the VIRTUO system software was acceptable.

Unresolved Anomalies:

An update was provided to the unresolved (‘open’) anomalies for the VIRTUO system intended for release. No unresolved anomalies remain that compromise product safety and efficacy or prevent operation of a function critical to the intended use of the system where alternative work-arounds are not available. The majority of the unresolved anomalies can result (at worst) in a minor inconvenience to the end user or are transparent and can have no effect on performance. Of the 17 unresolved anomalies remaining that may require a work-around to ensure functional operation of the system, mitigations (e.g., additional instructions in the labeling; disabling of interfering noncritical functionalities; etc.) and workarounds were put into place to help ensure that these anomalies do not impair the end user’s ability to use the device.

3. Specimen Identification:

Specimen Identification is performed using barcode labels (both testing site as well as bottle-specific barcodes) or bottle and patient identification information can be entered manually.

# 4. Specimen Sampling and Handling:

The VIRTUO instrument provides automated loading and unloading of culture bottles.

Once a sample bottle is loaded on the conveyor, handling of the sample bottle is generally not required until a result is obtained and the bottle automatically unloads. Automatic bottle scans determine the bottle ID and bottle type from the bioMérieux bottle ID. The system also reads and assigns user applied barcodes, such as the accession ID, patient ID, or alternate bottle ID. For bottles with a bioMérieux 2D barcode, the system automatically determines the expiration date, the lot number, and information about the authenticity of the bottle. For bottles with a fill-to line etched onto the label, the system determines the sample volume within the bottle and alerts if the bottle is underfilled or overfilled.

Positive bottle results are audible by a user-configured sound as well. The system supervises the reading of the culture bottles and contains decision-making algorithms to determine which samples are positive or negative. The instrument automatically unloads all identified positive and negative bottles from any instrument in a bank when the instrument is configured to automatically unload bottles after testing and a final test result is available. The instrument also has an option for manual bottle loading and unloading.

5. Calibration:

Reflectance Calibration Standards are included within each VIRTUO instrument for automated QC and Calibration procedures.

6. Quality Control: See Section M.1.b above.

# P. Other Supportive Instrument Performance Characteristics Data Not Covered In The “Performance Characteristics” Section above:

# Q. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# R. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.